tag:blogger.com,1999:blog-7787446685613522502024-03-28T10:41:00.901-03:00Clipping CRF/RSCentro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.comBlogger6075125tag:blogger.com,1999:blog-778744668561352250.post-50264464579204098632024-03-28T10:40:00.002-03:002024-03-28T10:40:10.367-03:00CLIPPING CRF/RS 28/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/03/2024/saude-lanca-cursos-sobre-vigilancia-epidemiologica-de-hiv-aids-sifilis-hepatites-e-tuberculose">Saúde
lança cursos sobre vigilância epidemiológica de HIV, aids, sífilis, hepatites
e tuberculose</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/03/2024/saude-alerta-para-os-riscos-de-tratamentos-caseiros-ou-uso-de-medicamentos-sem-orientacao">Saúde
alerta para os riscos de tratamentos caseiros ou uso de medicamentos sem
orientação</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/03/2024/estudos-realizados-em-animais-mostram-que-a-rapamicina-pode-aumentar-a-longevidade-entre-10-e-30-">Estudos
realizados em animais mostram que a rapamicina pode aumentar a longevidade
entre 10% e 30%</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/03/2024/como-a-industria-farmaceutica-vem-revolucionando-o-tratamento-do-cancer">Como
a indústria farmacêutica vem revolucionando o tratamento do câncer</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/27/03/2024/por-que-cresce-tanto-a-violencia-contra-as-mulheres-">Por
que cresce tanto a violência contra as mulheres?</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/saiba-quais-sao-as-comorbidades-elegiveis-para-a-vacinacao-contra-a-gripe">Saiba
quais são as comorbidades elegíveis para a vacinação contra a gripe</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/boletim-traz-principais-acoes-de-vigilancia-sanitaria-no-mes-de-marco">Boletim
traz principais ações de vigilância sanitária no mês de março</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-publica-edital-de-chamamento-para-lista-de-espera-de-comite-tecnico-da-farmacopeia">Anvisa
publica edital de chamamento para lista de espera de comitê técnico da
Farmacopeia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/brasil-e-escolhido-para-estudo-de-caso-sobre-micotoxinas-em-cereais">Brasil
é escolhido para estudo de caso sobre micotoxinas em cereais</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=1&totalArquivos=154">Lei
nº 14.831, de 27 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Institui o Certificado Empresa Promotora da Saúde Mental e
estabelece os requisitos para a concessão da certificação.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=123&totalArquivos=154">Portaria
SAES/MS nº 1.560, de 26 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera atributos de procedimento na Tabela de Procedimentos,
Medicamentos, Órteses, Próteses e Materiais Especiais do Sistema Único de
Saúde - SUS.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=137&totalArquivos=154">1.190</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=138&totalArquivos=154">1.191</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=132&totalArquivos=154">1.186</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=134&totalArquivos=154">1.187</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=137&totalArquivos=154">1.188</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=137&totalArquivos=154">1.189</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/03/2024&jornal=515&pagina=138&totalArquivos=154">1.192</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-28&pg=21">Instrução
Normativa IPE Saúde nº 09, de 27 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Institui as Diretrizes de Cobertura dos
Tratamentos Oncológicos do Sistema IPE Saúde.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-30-2024-%20Secretaria%20de%20Plen%C3%A1rias.pdf">Portaria
nº 30/2024, de 27 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a substituição
da função Secretaria De Plenárias do CRF/RS.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-75445434312085512272024-03-27T08:49:00.001-03:002024-03-27T08:49:01.293-03:00CLIPPING CRF/RS 27/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/26/03/2024/estudo-indica-que-alergias-alimentares-podem-ser-reduzidas-com-medicamento-para-asma">Estudo
indica que alergias alimentares podem ser reduzidas com medicamento para asma</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/26/03/2024/percepcao-sobre-a-importancia-dos-farmaceuticos-na-area-da-saude-foi-a-que-mais-cresceu">Percepção
sobre a importância dos farmacêuticos, na área da saúde, foi a que mais
cresceu</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/26/03/2024/copaiba-medicamento-contra-o-zika-pode-ser-criado-com-oleo-de-planta-indigena">Copaíba:
medicamento contra o zika pode ser criado com óleo de planta indígena</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/cosmetovigilancia-anvisa-divulga-perguntas-respostas-e-convida-para-consulta-publica">Cosmetovigilância:
Anvisa divulga Perguntas & Respostas e convida para consulta pública</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=86&totalArquivos=167">Portaria
GM/MS nº 3.393, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Prorroga o prazo de atuação do Grupo de Trabalho estabelecido na
Portaria GM/MS nº 1.334, de 22 de setembro de 2023, com objetivo de
elaboração do plano estratégico para prevenção, preparação e resposta a
pandemias<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=148&totalArquivos=167">Portaria
SAES/MS nº 1.546, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera atributos de procedimentos na Tabela de Procedimentos,
Medicamentos, Órteses, Próteses e Materiais Especiais do SUS<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=149&totalArquivos=167">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SAES/MS</span> nº 1.549, de 22 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Inclui procedimento relacionado a Esterilização, na Tabela de
Procedimentos, Medicamentos, Órteses, Próteses e Materiais Especiais do SUS<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=150&totalArquivos=167">Portaria<span style="color: windowtext; font-family: "Times New Roman",serif; font-size: 12.0pt; text-decoration: none; text-underline: none;"> </span><span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SAPS/MS</span>
nº 16, de 25 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Institui Câmara Técnica Assessora para prestar consultoria e
assessoramento para revisão da Política Nacional de Atenção Integral à Saúde
da Mulher<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=151&totalArquivos=167">1.172</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=151&totalArquivos=167">1.173</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=159&totalArquivos=167">1.179</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=151&totalArquivos=167">1.174</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=152&totalArquivos=167">1.175</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=154&totalArquivos=167">1.176</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=158&totalArquivos=167">1.177</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=27/03/2024&jornal=515&pagina=159&totalArquivos=167">1.178</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-27&pg=112">Protocolo:
2024000979158</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
utilizar medicamentos à base de substâncias RETINÓICAS, constantes da relação
C2 Portaria n.º 344/98-SVS/MS, o estabelecimento constante da seguinte
relação: Razão Social: Comércio de Medicamentos Brair Ltda Endereço: Pinheiro
Machado, 908 Município: Cruz Alta CNPJ: 88.212.113/0115-60 Nº Processo:
24/2000-0040832-1</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-27&pg=113">Protocolo:
2024000979152</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de SUBSTÂNCIAS RETINOICAS, constantes da
relação C-2, Portaria SVS/MS 344/98, o seguinte estabelecimento: Razão
Social: FARMÁCIA DA TATI LTDA. CNPJ: 53.932.780/0001-74 Endereço: Rua Neco
Januário nº 986, sala 03, Centro CEP: 97900-000 Município: Cerro Largo / RS</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/DeliberacaoDePlenaria-1793.2024-PF.PJ..pdf">Deliberação
de Plenária nº 1.793/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Concessão de inscrição e
baixa de profissionais e registro e baixa de estabelecimentos junto ao CRF/RS.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-26817339671061060862024-03-26T09:36:00.001-03:002024-03-26T09:36:02.210-03:00CLIPPING CRF/RS 26/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/25/03/2024/tysabri-e-ozempic-aumento-na-comercializacao-de-medicamentos-falsificados-preocupa-autoridades">Tysabri
e Ozempic: aumento na comercialização de medicamentos falsificados preocupa
autoridades</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/25/03/2024/cff-entrega-a-comenda-do-merito-farmaceutico-aos-profissionais-destaque-de-2023"><span style="mso-fareast-language: EN-US;">CFF entrega a Comenda do Mérito
Farmacêutico aos profissionais destaque de 2023</span></a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/25/03/2024/entresto-medicamento-para-tratar-insuficiencia-cardiaca-em-adultos-deve-ganhar-versao-generica"><span style="mso-fareast-language: EN-US;">Entresto: medicamento para tratar
insuficiência cardíaca em adultos deve ganhar versão genérica</span></a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/aviso-de-pauta-boletim-com-dados-da-violencia-contra-a-mulher-sera-lancado-nesta-quarta-feira"><span style="mso-fareast-language: EN-US;">Aviso de pauta: Boletim com dados da
violência contra a mulher será lançado nesta quarta-feira</span></a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-font-kerning: 0pt; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/prazo-para-envio-do-relatorio-de-comercializacao-de-medicamentos-prorrogado">Prazo
para envio do relatório de comercialização de medicamentos é prorrogado</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-publica-quatro-consultas-publicas-sobre-alimentos"><span style="mso-fareast-language: EN-US;">Anvisa publica quatro consultas públicas
sobre alimentos</span></a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-font-kerning: 0pt; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/publicado-resultado-do-monitoramento-da-qualidade-de-saneantes-hospitalares-de-alto-risco">Publicado
resultado do monitoramento da qualidade de saneantes hospitalares de alto
risco</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/rio-grande-do-sul-recebe-r-16-3-milhoes-para-a-assistencia-farmaceutica-como-reforco-no-combate-a-dengue"><span style="mso-fareast-language: EN-US;">Rio Grande do Sul recebe R$ 16,3 milhões
para a assistência farmacêutica como reforço no combate à dengue</span></a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=91&totalArquivos=114">Instrução
Normativa ANS nº 34, de 25 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre processos de contratação de serviços e realização
de outras despesas previstas na Resolução Normativa nº 524, de 29 de abril de
2022, no curso das liquidações extrajudiciais decretadas pela ANS<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=93&totalArquivos=114">Resolução-RE
nº 1.164, de 25 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: VITAO ALIMENTOS LTDA - CNPJ: 04869719000114 Produto
- (Lote): AVEIA EM FLOCOS FINOS INTEGRAL MARCA SABORES DO CAMPO E VITAO
ALIMENTOS (63480); AVEIA EM FLOCOS FINOS INTEGRAL MARCA SABORES DO CAMPO E
VITAO ALIMENTOS (61980); AVEIA EM FLOCOS FINOS INTEGRAL MARCA SABORES DO
CAMPO E VITAO ALIMENTOS (62392); AVEIA EM FLOCOS FINOS INTEGRAL MARCA SABORES
DO CAMPO E VITAO ALIMENTOS (61979); Tipo de Produto: Alimento Expediente nº:
0361883/24-8 Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização: Proibição - Comercialização, Distribuição, Uso
Recolhimento - Voluntário Motivação: Considerando o comunicado de
recolhimento voluntário recebido da empresa VITAO ALIMENTOS LTDA (CNPJ:
04.869.719/0001-14), referente ao produto AVEIA EM FLOCOS FINOS INTEGRAL,
marca SABORES DO CAMPO e VITAO ALIMENTOS, lotes 61979 (Prazo de validade:
06/02/2025; Conteúdo líquido: 400g); 62392 (Prazo de validade: 20/02/2025;
Conteúdo líquido: 400g); 61980 (Prazo de validade: 07/02/2025; Conteúdo líquido:
170g) e 63480 (Prazo de validade: 12/03/2025; Conteúdo líquido: 400g), devido
ao uso de matéria-prima vencida na sua fabricação, tendo em vista o inciso
XV, art. 7º da Lei nº 9.782, de 26 de janeiro de 1999 e o art. 8º da
Resolução da Diretoria Colegiada-RDC nº 655, de 24 de março de 2022. Foram
infringidos: item 8.1.2 do anexo da Portaria n. 326/1997; item 4.1.9 do anexo
II da RDC n. 275/2002; inciso I do art. 4º da RDC n. 727/2022, art. 21 e
inciso III do art. 48 do Decreto Lei n. 986/1969. .........................................
<o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: MONDELEZ BRASIL LTDA - CNPJ: 33033028002047 Produto
- (Lote): TOBLERONE CHOCOLATE COM LECHE Y NOUGAT COM MIEL Y ALMENTRAS (lote
OOY4333922 - lotes embalagens individuais: OOY4033922, OOY4133922,
OOY4233922); TOBLERONE CHOCOLATE COM LECHE Y NOUGAT COM MIEL Y ALMENTRAS
(lote OOY4335151 - lotes embalagens individuais: OOY4035151, OOY4135151,
OOY4235151); TOBLERONE CHOCOLATE COM LECHE Y NOUGAT COM MIEL Y ALMENTRAS
(lote OOY4335043 - lotes embalagens individuais: OOY4035043,
OOY4135043);TOBLERONE CHOCOLATE COM LECHE Y NOUGAT COM MIEL Y ALMENTRAS (lote
OOY4333923 - lotes embalagens individuais: OOY4033923, OOY4133923, O OY 4 2 3
3 9 2 3 ) ; Tipo de Produto: Alimento Expediente nº: 0366896/24-7 Assunto:
70351 - Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Proibição - Comercialização, Distribuição, Uso Recolhimento - Voluntário
Motivação: Considerando o comunicado de recolhimento voluntário recebido da
empresa MONDELEZ BRASIL LTDA, CNPJ 33.033.028/0020-47, referente ao chocolate
de marca TOBLERONE, com rotulagem em espanhol e denominação "CHOCOLATE
COM LECHE Y "NOUGAT" COM MIEL Y ALMENTRAS", apresentado em
forma de barra de 100 g em embalagem metálica e papel cartão, com prazos de
validade 26/12/24, 15/03/2025 e 23/03/2025, devido à ausência de informações
obrigatórias de rotulagem em português, incluindo as advertências sobre
alergênicos, lactose e glúten, tendo em vista o inciso XV, art. 7º da Lei nº
9.782, de 26 de janeiro de 1999 e o art. 8º da Resolução da Diretoria
Colegiada-RDC nº 655, de 24 de março de 2022). Foram infringidos: inciso III
do art. 48 do Decreto Lei 986, de 21 de outubro de 1969, art. 8º da Resolução
da Diretoria Colegiada - RDC 727, de 1º de julho de 2022, e Lei 10.674, de 16
de maio de 2003.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=102&totalArquivos=114">1.169</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=102&totalArquivos=114">1.170</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=103&totalArquivos=114">1.171</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=93&totalArquivos=114">1.165</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=97&totalArquivos=114">1.166</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=102&totalArquivos=114">1.167</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=102&totalArquivos=114">1.168</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Fabricação.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=26/03/2024&jornal=515&pagina=93&totalArquivos=114">1.107</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-35443362387703914062024-03-25T10:50:00.003-03:002024-03-25T10:50:19.221-03:00CLIPPING CRF/RS 25/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/22/03/2024/victoza-e-saxenda-terao-suas-patentes-expiradas-neste-primeiro-semestre">Victoza
e Saxenda terão suas patentes expiradas neste primeiro semestre</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/22/03/2024/cff-recebe-ministra-do-tst-para-tratar-de-insalubridade-para-o-farmaceutico">CFF
recebe ministra do TST para tratar de insalubridade para o farmacêutico</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/mais-de-300-municipios-ja-foram-capacitados-para-novas-estrategias-no-combate-a-dengue">Mais
de 300 municípios já foram capacitados para novas estratégias no combate à
dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/aumento-nas-internacoes-por-gripe-influenza-reforca-necessidade-de-vacinacao">Aumento
nas internações por gripe influenza reforça necessidade de vacinação</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/esclarecimentos-sobre-a-transparencia-das-filas-de-analise-na-anvisa">Esclarecimentos
sobre a transparência das filas de análise na Anvisa</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-amplia-para-quatro-anos-prazo-de-validade-do-certificado-de-boas-praticas-de-fabricacao">Anvisa
amplia para quatro anos prazo de validade do Certificado de Boas Práticas de
Fabricação</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=79&totalArquivos=168">Instrução
Normativa - IN nº 289, de 20 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Estabelece, nos termos da Resolução da Diretoria Colegiada - RDC
nº 741, de 10 de agosto de 2022, os critérios aplicados para o procedimento
otimizado de análise em que se utiliza das avaliações conduzidas por
Autoridade Regulatória Estrangeira Equivalente (AREE) para análise das
petições de registro e pósregistro de medicamentos, produtos biológicos,
vacinas e de carta de adequação de dossiê de insumo farmacêutico ativo
(CADIFA) em território naciona<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=78&totalArquivos=168">Consulta
Pública nº 1.245, de 20 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 45 (quarenta e cinco) dias para
envio de comentários e sugestões ao texto da proposta de Resolução da
Diretoria Colegiada - RDC que dispõe sobre a validação de métodos
bioanalíticos e análise de amostras de estudo para submissões regulatórias de
medicamentos industrializados de uso humano, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=134&totalArquivos=168">1.089</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.159</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.160</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.161</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=78&totalArquivos=168">1.157</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=134&totalArquivos=168">1.155</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=135&totalArquivos=168">1.156</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.158</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.162</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=138&totalArquivos=168">1.139</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=139&totalArquivos=168">1.140</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=139&totalArquivos=168">1.141</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=139&totalArquivos=168">1.142</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Distribuição e/ou Armazenagem.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=132&totalArquivos=168">1.101</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Fabricação.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=131&totalArquivos=168">1.099</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=132&totalArquivos=168">1.100</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=132&totalArquivos=168">1.102</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=133&totalArquivos=168">1.103</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=133&totalArquivos=168">1.108</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=133&totalArquivos=168">1.109</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=133&totalArquivos=168">1.110</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=133&totalArquivos=168">1.111</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=134&totalArquivos=168">1.163</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Alimentos.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=83&totalArquivos=168">1.126</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Medicamentos e Produtos Biológicos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=84&totalArquivos=168">1.130</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=86&totalArquivos=168">1.131</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=86&totalArquivos=168">1.132</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=87&totalArquivos=168">1.104</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Tecnologia de Produtos
para a Saúde.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=119&totalArquivos=168">1.115</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=119&totalArquivos=168">1.116</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=123&totalArquivos=168">1.117</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=126&totalArquivos=168">1.118</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=127&totalArquivos=168">1.119</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=129&totalArquivos=168">1.120</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 8;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência-Geral de Produtos Biológicos, Radiofármacos,
Sangue, Tecidos, Células, Órgãos e Produtos de Terapias Avançadas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=87&totalArquivos=168">1.105</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=88&totalArquivos=168">1.106</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 9;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registro ou notificação de produtos para a saúde, cancelamento<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=89&totalArquivos=168">1.112</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 10; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Resoluções, insubsistência.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=25/03/2024&jornal=515&pagina=134&totalArquivos=168">1.154</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-25&pg=79">Protocolo:
2024000977741</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de RETINÓIDES (LISTA “C2”), Portaria SVS/MS
344/98, os estabelecimentos constantes da seguinte relação: Razão Social:
Farmácias Ultramed Popular Ltda Endereço: Rua Paulino Pedro Bridi, nº 01 Centro
Sobradinho CGC/CNPJ: 8.928.058/0001-01 Processo nº: 24/2000-0038152-0</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-25&pg=79">Protocolo:
2024000977742</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de substancias RETINÓICAS, constantes da
relação C-2, Portaria SVS/MS 344/98, o seguinte estabelecimento: Razão
Social: Drogaria Pilz Dois Ltda Endereço: Rua Armando Ruschel, 2147 bairro
Bela Vista – Venâncio Aires - RS CNPJ: 46.273.878/0002-82</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-25&pg=82">Protocolo:
2024000977745</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de RETINÓIDES (LISTA “C2”), Portaria SVS/MS
344/98, os estabelecimentos constantes da seguinte relação: Razão Social:
Farmácias Ultramed Popular Ltda Endereço: Rua Sete de Setembro, 1337, Centro
– Cachoeira do Sul CGC/CNPJ: 08.928.058/0005-35 Processo nº:
24/2000-0038147-4</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-25&pg=82">Protocolo:
2024000977747</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de RETINÓIDES (LISTA “C2”), Portaria SVS/MS
344/98, os estabelecimentos constantes da seguinte relação: Razão Social:
Farmácias Ultramed Popular Ltda Endereço: Av. Brasil, 3368 , Marina – Cachoeira
do Sul CGC/CNPJ: 08.928.058/0016-98 Processo nº: 24/2000-0038123-7</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-9134698566498032772024-03-22T09:42:00.000-03:002024-03-22T09:42:16.618-03:00CLIPPING CRF/RS 22/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/crf-rs--participa--da--69a--reuniao--geral--dos--conselhos--de--farmacia">CRF-RS
PARTICIPA DA 69ª REUNIÃO GERAL DOS CONSELHOS DE FARMÁCIA</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/equipes-da-ses-e-do-ministerio-da-saude-discutem-qualificacao-do-atendimento-em-oncologia">Equipes
da SES e do Ministério da Saúde discutem qualificação do atendimento em
oncologia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-suspende-lotes-do-suplemento-alimentar-de-bacillus-claussi-da-marca-neogermina">Anvisa
suspende lotes do Suplemento Alimentar de Bacillus claussi da marca
Neogermina</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinar-apresenta-propostas-de-inclusao-e-revisao-de-monografias-na-farmacopeia-brasileira">Webinar
apresenta propostas de inclusão e revisão de monografias na Farmacopeia
Brasileira</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-novo-painel-agenda-regulatoria">Anvisa
lança novo painel de acompanhamento da agenda regulatória</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=89&totalArquivos=143">Resolução
da Diretoria Colegiada - RDC nº 850, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução da Diretoria Colegiada - RDC nº 497, de 20 de
maio de 2021, que dispõe sobre os procedimentos administrativos para
concessão de Certificação de Boas Práticas de Fabricação e de Certificação de
Boas Práticas de Distribuição e/ou Armazenagem.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=90&totalArquivos=143">Resolução
da Diretoria Colegiada -RDC nº 851, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução da Diretoria Colegiada - RDC n° 73, de 7 de
abril de 2016, que dispõe sobre mudanças pós-registro, cancelamento de
registro de medicamentos com princípios ativos sintéticos e semissintéticos e
dá outras providências<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=91&totalArquivos=143">Resolução
da Diretoria Colegiada - RDC nº 852, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução da Diretoria Colegiada - RDC n° 585, de 10 de
dezembro de 2021, que aprova e promulga o Regimento Interno da Agência
Nacional de Vigilância Sanitária - Anvisa<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=91&totalArquivos=143">Resolução
da Diretoria Colegiada - RDC nº 853, de 21 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera e prorroga a Resolução da Diretoria Colegiada - RDC n°
567, de 29 de setembro de 2021<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=80&totalArquivos=143">Consulta
Pública nº 1.241, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 45 (quarenta e cinco) dias para
envio de comentários e sugestões ao texto da proposta de Resolução RDC que
altera a Resolução da Diretoria Colegiada - RDC nº 56, de 16 de novembro de
2012, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=80&totalArquivos=143">Consulta
Pública nº 1.242, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 90 (noventa) dias para envio de
comentários e sugestões ao texto da proposta de Resolução de Diretoria
Colegiada que dispõe sobre os requisitos sanitários para fórmulas infantis
para lactentes e crianças de primeira infância, alimentos de transição e
alimentos à base de cereais para lactentes e crianças de primeira infância,
fórmulas para nutrição enteral e fórmulas dietoterápicas para erros inatos do
metabolismo, conforme Anexo<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=80&totalArquivos=143">Consulta
Pública nº 1.243, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 90 (noventa) dias para envio de
comentários e sugestões ao texto da proposta de Instrução Normativa que
estabelece os requisitos de composição e qualidade, alegações de conteúdo e
nutricionais e lista de constituintes autorizados para fórmulas infantis,
alimentos de transição e alimentos à base de cereais para lactentes e
crianças de primeira infância, fórmulas para nutrição enteral e fórmulas
dietoterápicas para erros inatos do metabolismo, conforme Anexo<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=80&totalArquivos=143">Consulta
Pública nº 1.244, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 60 (sessenta) dias para envio de
comentários e sugestões ao texto da proposta de Resolução - RDC que altera a
Resolução da Diretoria Colegiada - RDC nº 326, de 3 de dezembro de 2019,
conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=95&totalArquivos=143">Resolução-RE
nº 1.133, de 21 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: CAPSUL BRASIL INDUSTRIA E COMERCIO S.A. - CNPJ:
29822523000103 Produto - (Lote): SUPLEMENTO ALIMENTAR EM GOTAS DA MARCA
REVERAVIT (TODOS); Tipo de Produto: Alimento Expediente nº: 0352885/24-5
Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização: Recolhimento Suspensão - Comercialização, Distribuição,
Fabricação, Propaganda, Uso Motivação: Considerando fabricação e
comercialização do Suplemento Alimentar em gotas da marca REVERAVIT com
ingredientes não avaliados para segurança de uso sublingual em alimentos,
comercializado no site https://reveravit.com/. Foram infringidos os seguintes
dispositivos legais: Arts. 3, 28, 41, 48 do Decreto-Lei nº 986/1969; Anexo da
Resolução nº 17, de 30 de abril de 1999; Item 5.1 da Resolução 23/2000; os
art. 4 e 8 da RDC nº 243/2018; Anexo I da Instrução Normativa - IN nº
28/2018; tendo em vista o inciso XV, art. 7º da Lei nº 9.782/1999 e o art. 9º
da Resolução da Diretoria Colegiada-RDC nº 655/2022.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 6; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=95&totalArquivos=143">Resolução-RE
nº 1.134, de 21 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: SUPERNOVA INDUSTRIA COMERCIO E SERVICOS LTDA - CNPJ:
10936347000102 Produto - (Lote): GEL COLA SER MULHER(TODOS); Tipo de Produto:
Cosmético Expediente nº: 0350158/24-2 Assunto: 70351 - Ações de Fiscalização
em Vigilância Sanitária Ações de fiscalização: Recolhimento Suspensão -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando comercialização de produto cosmético com substância conservante
não permitida para produtos que não se enxáguam, conforme estabelecido na
Resolução-RDC n.º 528, de 4 de agosto de 2021 e tendo em vista o previsto nos
arts 6º,7º e inciso I do art. 27 da Lei 6360, de 23 de setembro de 1976.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=101&totalArquivos=143">1.124</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=101&totalArquivos=143">1.125</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=101&totalArquivos=143">1.127</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=101&totalArquivos=143">1.129</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=95&totalArquivos=143">1.121</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=99&totalArquivos=143">1.122</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=100&totalArquivos=143">1.123</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=22/03/2024&jornal=515&pagina=101&totalArquivos=143">1.128</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Delibera%C3%A7%C3%A3o%20de%20plen%C3%A1ria%201792-2024%20final.pdf">Deliberação
de Plenária 1.792/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a distribuição
e julgamento de processos administrativos do CRF/RS e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-70219496685959407312024-03-21T10:43:00.002-03:002024-03-21T10:43:44.462-03:00CLIPPING CRF/RS 21/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.25pt; mso-para-margin-top: 6.0pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/anvisa--republica--nota--tecnica--sobre--servicos--de--estetica--e--embelezamento">Anvisa
republica nota técnica sobre serviços de estética e embelezamento</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-font-weight: normal; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/20/03/2024/saude-oferta-cursos-sobre-dengue-para-profissionais-de-saude-e-interessados">Saúde
oferta cursos sobre dengue para profissionais de saúde e interessados</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/20/03/2024/profesp-oferece-curso-para-capacitacao-em-emergencias-biologicas">Profesp
oferece curso para capacitação em emergências biológicas</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/20/03/2024/farmaceutica-quer-lancar-medicamento-que-trata-cancer-em-2026">Farmacêutica
quer lançar medicamento que trata câncer em 2026</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/20/03/2024/farmalibras-vocabulario-portugues-libras-e-aplicativo-devem-ser-lancados-ainda-este-ano">Farmalibras:
Vocabulário Português-Libras e aplicativo devem ser lançados ainda este ano</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/21/03/2024/cff-e-crfs-realizam-reuniao-geral-do-sistema-em-brasilia">CFF
e CRFs realizam Reunião Geral do sistema, em Brasília</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/abertas-inscricoes-para-seminario-sobre-tuberculose-e-seguranca-alimentar">Abertas
inscrições para seminário sobre Tuberculose e Segurança Alimentar</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/plateia-do-south-summit-brazil-conhece-tecnologias-inovadoras-de-saude-do-estado">Plateia
do South Summit Brazil conhece tecnologias inovadoras de saúde do Estado</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-atualiza-lista-das-denominacoes-comuns-brasileiras">Anvisa
atualiza lista das Denominações Comuns Brasileiras</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/publicadaatualizacao-da-6a-edicao-da-farmacopeia-brasileira">Publicada atualização
da 6ª edição da Farmacopeia Brasileira</a></span></span><span style="font-family: "Calibri",sans-serif; font-size: 12.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: -4.15pt; mso-para-margin-top: 6.0pt; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos
Normativos DOU - Presidência/Ministério da Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=1&totalArquivos=149">Lei
nº 14.824, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe
sobre a composição, o funcionamento e a competência do Conselho Superior da
Justiça do Trabalho; e altera a Consolidação das Leis do Trabalho, aprovada
pelo Decreto-Lei nº 5.452, de 1º de maio de 1943.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=3&totalArquivos=149">Lei
nº 14.827, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Institui o
Dia Nacional do Cirurgião Oncológico.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=3&totalArquivos=149">Lei
nº 14.828, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a
Lei nº 11.326, de 24 de julho de 2006 (Lei da Agricultura Familiar), para
ampliar o âmbito do planejamento e da execução das ações da Política Nacional
da Agricultura Familiar e Empreendimentos Familiares Rurais.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=114&totalArquivos=149">Portaria
GM/MS nº 3.225, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Institui a
Comissão Nacional para Planejamento e Dimensionamento da Força de Trabalho no
Sistema Único de Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 5; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=116&totalArquivos=149">Portaria
SECTICS/MS nº 11, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Tornar sem
efeito a Portaria SECTICS/MS nº 7, de 5 de março de 2024 publicada no Diário
Oficial da União nº 46, de 7 de março de 2024, Seção 1, página 54 de 7 de
março de 2024, por ter sido publicada em duplicidade.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo DOU - Recolhimentos/suspensão de
produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=115&totalArquivos=149">Consulta
Pública SECTICS/MS nº 7, de 20 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">O
SECRETÁRIO DE CIÊNCIA, TECNOLOGIA E INOVAÇÃO E DO COMPLEXO
ECONÔMICO-INDUSTRIAL DA SAÚDE DO MINISTÉRIO DA SAÚDE torna pública, nos
termos do inciso III do art. 19-R da Lei nº 8.080, de 19 de setembro de 1990,
e do caput do art. 19 do Decreto nº 7.646, de 21 de dezembro de 2011,
consulta para manifestação da sociedade civil a respeito da recomendação do
Comitê de Medicamentos da Comissão Nacional de Incorporação de Tecnologias no
Sistema Único de Saúde - Conitec relativa à proposta de incorporação da rivastigmina
para o tratamento em indivíduos com doença de Parkinson e demência,
apresentada pela Secretaria de Ciência, Tecnologia e Inovação e do Complexo
Econômico-Industrial da Saúde - SECTICS/MS, nos autos de NUP
25000.178786/2023-03<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=115&totalArquivos=149">Consulta
Pública <span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 8, de 20 de março
de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">O
SECRETÁRIO DE CIÊNCIA, TECNOLOGIA E INOVAÇÃO E DO COMPLEXO
ECONÔMICO-INDUSTRIAL DA SAÚDE DO MINISTÉRIO DA SAÚDE torna pública, nos
termos do inciso III do art. 19-R da Lei nº 8.080, de 19 de setembro de 1990,
e do caput do art. 19 do Decreto nº 7.646, de 21 de dezembro de 2011,
consulta para manifestação da sociedade civil a respeito da recomendação do
Comitê de Protocolos Clínicos e Diretrizes Terapêuticas da Comissão Nacional
de Incorporação de Tecnologias no Sistema Único de Saúde - Conitec relativa à
proposta de aprovação do Protocolo de Uso da Terapia Fotodinâmica para o
Tratamento de Carcinoma Basocelular Superficial e Nodular, apresentada pela
Secretaria de Ciência, Tecnologia e Inovação e do Complexo
Econômico-Industrial da Saúde - SECTICS, nos autos de NUP
25000.130479/2023-33<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=116&totalArquivos=149">Consulta
Pública <span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 9, de 20 de março
de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">O
SECRETÁRIO DE CIÊNCIA, TECNOLOGIA E INOVAÇÃO E DO COMPLEXO
ECONÔMICO-INDUSTRIAL DA SAÚDE DO MINISTÉRIO DA SAÚDE torna pública, nos
termos do inciso III do art. 19-R da Lei nº 8.080, de 19 de setembro de 1990,
e do caput do art. 19 do Decreto nº 7.646, de 21 de dezembro de 2011,
consulta para manifestação da sociedade civil a respeito da recomendação do
Comitê de Protocolos Clínicos e Diretrizes Terapêuticas da Comissão Nacional
de Incorporação de Tecnologias no Sistema Único de Saúde - Conitec relativa à
proposta de atualização do Protocolo Clínico e Diretrizes Terapêuticas de
Retinopatia Diabética, apresentada pela Secretaria de Ciência, Tecnologia e
Inovação e do Complexo Econômico-Industrial da Saúde - SECTICS, nos autos de
NUP 25000.159906/2023-65<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=116&totalArquivos=149">Consulta
Pública <span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 10, de 20 de março
de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">O
SECRETÁRIO DE CIÊNCIA, TECNOLOGIA E INOVAÇÃO E DO COMPLEXO
ECONÔMICO-INDUSTRIAL DA SAÚDE DO MINISTÉRIO DA SAÚDE torna pública, nos
termos do inciso III do art. 19-R da Lei nº 8.080, de 19 de setembro de 1990,
e do caput do art. 19 do Decreto nº 7.646, de 21 de dezembro de 2011,
consulta para manifestação da sociedade civil a respeito da recomendação do
Comitê de Protocolos Clínicos e Diretrizes Terapêuticas da Comissão Nacional
de Incorporação de Tecnologias no Sistema Único de Saúde - Conitec relativa à
proposta de atualização do Protocolo Clínico e Diretrizes Terapêuticas da
Esclerose Múltipla, apresentada pela a Secretaria de Ciência, Tecnologia e
Inovação e do Complexo Econômico-Industrial da Saúde - SECTICS, nos autos de
NUP 25000.164114/2023-11<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=117&totalArquivos=149">Resolução-RE
nº 1.091, de 20 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa:
DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote): SUPLEMENTO ALIMENTAR EM
CÁPSULAS DAS MARCAS LEVER/ELEVE BY SUPER (TODOS); Tipo de Produto: Alimento
Expediente nº: 0346104/24-1 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a denúncia de falsificação do Suplemento Alimentar em cápsulas
das marcas LEVER/ELEVE BY SUPER comercializado por lojistas na plataforma
eletrônica de venda Magazine Luiza: Perfil RPCAPS (50.254.764 Raphael de
Sousa Antunes - CNPJ 50.254.764/0001-81); https://www.magazineluiza.com.br/lojista/reisupp/
(52.163.578 Leandro Santos da Silva - CNPJ: 52.163.578/0001-62); e
https://www.magazineluiza.com.br/lojista/novavidasuplementos/ (Amanda
Ferreira da Silva - CNPJ 49.301.272/0001-10). A empresa responsável pelo produto
original, Super e Suplementos Alimentares LTDA - 43.683.727/0001-23, não
reconhece tal produção. Foram infringidos os dispositivos legais: arts. 10,
21, 41, 45, 46 e 48 do Decreto-Lei nº 986, de 21 de outubro de 1969; art. 6,
incisos IX e X do art. 7 e art. 29 da Resolução da Diretoria Colegiada - RDC
nº 727, de 1° de julho de 2022, tendo em vista o inciso XV, art. 7º da Lei nº
9.782, de 26 de janeiro de 1999<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 3.3pt; mso-para-margin-top: 6.0pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo DOU - ANVISA – Decisões
administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE
de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas
de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 3.3pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=122&totalArquivos=149">1.087</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=123&totalArquivos=149">1.088</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=123&totalArquivos=149">1.088</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 1.7pt; mso-para-margin-top: 6.0pt; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE
de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 3.3pt; mso-para-margin-top: 6.0pt; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=117&totalArquivos=149">1.083</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=120&totalArquivos=149">1.084</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=122&totalArquivos=149">1.085</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=122&totalArquivos=149">1.086</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=123&totalArquivos=149">1.090</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=123&totalArquivos=149">1.094</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=123&totalArquivos=149">1.095</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=124&totalArquivos=149">1.097</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=21/03/2024&jornal=515&pagina=124&totalArquivos=149">1.098</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-21&pg=110">Protocolo:
2024000976515</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 0cm; margin-top: 6.0pt; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para comercializar
medicamentos à base de RETINÓIDES (LISTA “C2”), Portaria SVS/MS 344/98, os
estabelecimentos constantes da seguinte relação: Razão Social: Bonfada &
Bonfada Comércio de Medicamentos Ltda- ME Endereço: Rua Sete de Setembro, 888
Centro Cachoeira do Sul CGC/CNPJ: 15.142.774/0001-24 Processo nº:
24/2000-0035710-7</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-10962427614273436612024-03-20T09:09:00.003-03:002024-03-20T09:09:32.197-03:00CLIPPING CRF/RS 20/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/comunicado--importante-:--golpe--em--farmacias-">Comunicado
Importante: Golpe em Farmácias</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/notificacao--compulsoria--de--doencas-:--entenda--como--funciona-">Notificação
compulsória de doenças: Entenda como funciona</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/19/03/2024/tecnologia-farmaceuticos-desenvolvem-aplicativo-para-pesquisas-sobre-medicamentos-fitoterapicos">Tecnologia:
farmacêuticos desenvolvem aplicativo para pesquisas sobre medicamentos
fitoterápicos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/19/03/2024/medicamentos-e-insonia">Medicamentos
e insônia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/ses-antecipa-vacinacao-contra-a-gripe-no-rs-em-2024">SES
antecipa vacinação contra a gripe no RS em 2024</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-autoriza-empresa-a-importar-celulas-germinativas-e-embrioes">Anvisa
autoriza empresa a importar células germinativas e embriões</a></span></span><span style="color: #0c326f; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-text-raise: 0pt; position: relative; top: 0pt;"><o:p></o:p></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-aprova-norma-para-aproveitamento-de-avaliacoes-de-autoridades-estrangeiras-equivalentes">Anvisa
aprova norma para aproveitamento de avaliações de autoridades estrangeiras
equivalentes</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/gauchos-receberao-135-novas-unidades-basicas-de-saude">Gaúchos
receberão 135 novas Unidades Básicas de Saúde</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=58&totalArquivos=164">Portaria
GM/MS nº 3.385, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre o incremento excepcional do financiamento federal
do Componente Básico da Assistência Farmacêutica, no âmbito do Sistema Único
de Saúde<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=117&totalArquivos=164">Resolução
Normativa ANS nº 602, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução Normativa ANS nº 593, de 19 de dezembro de
2023<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">Resolução-RE
nº 1.069, de 18 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: Desconhecida - CNPJ: Desconhecido Produto - (Lote): KIT
IBMP TR COVID AG - REGISTRO N. 80780040006 (78542366 (validade 08/24)); Tipo
de Produto: Produtos para diagnóstico de uso in vitro Expediente nº:
0324122/24-0 Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização: Apreensão Proibição - Comercialização, Distribuição,
Fabricação, Importação, Propaganda, Uso Motivação: Considerando que o
Instituto de Biologia Molecular do Paraná (IBMP) detentor do registro do produto
denominado: Kit IBMP TR COVID Ag, de número de registro 80780040006,
identificou no mercado unidades deste produto com características divergentes
das constantes na embalagem original, sendo constatada fraude dos lotes
220562Z037 e 220562Z035, haja vista que a validade original desses produtos
era fevereiro/2023 e foram encontrados no mercado nacional o produto com uma
etiqueta sobreposta sobre a original, contendo número de lote (78542366) e
validade (08/2024), lote este que não foi fabricado pelo IBMP, tratando-se,
portanto, de falsificação, conforme o art. 7º, inciso XV da Lei nº 9.782/1999
e em desacordo com o art. 10, inciso XXVIII da Lei nº. 6.437/1977.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">Resolução-RE
nº 1.070, de 18 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: PHILIPS MEDICAL SYSTEMS LTDA - CNPJ: 58.295.213/0001-78
Produto - (Lote): APLICADOR ENDOSCOPICO DE MULTIPLOS CLIPS (a partir de
05/07/2023); MISTURADOR KYPHON® (a partir de 05/07/2023); Protetor de Incisão
Surgisleeve (a partir de 05/07/2023); Renasys GO Canister (a partir de
05/07/2023); Renasys Go Terapia de Pressão Negativa para Feridas - Portátil
(a partir de 05/07/2023); RENASYS TOUCH - Terapia de Feridas por Pressão
Negativa (a partir de 05/07/2023); Tesoura HARMONIC 1100 (a partir de 05/07/2023);
TROCARTES CIRÚRGICOS ENDOPATH XCEL (a partir de 05/07/2023); Tipo de Produto:
Produtos para Saúde (Correlatos) Expediente nº: 0290217/24-6 Assunto: 70351 -
Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Suspensão - Comercialização, Distribuição, Importação, Propaganda Motivação:
Considerando o Certificado de Boas Práticas de Fabricação internacional
vencido desde 05/07/2023 e sem pedido de renovação, para a empresa NPA de
México S. de R.L. de C.V., localizado em Blvd. Héctor Terán Terán # 20.662-C,
Col. Murua Oriente, Tijuana, 22565 - México, de acordo com o disposto nos
artigos 6° e 7° da Lei n. 6.360/1976.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">Resolução-RE
nº 1.080, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: Desconhecida - CNPJ: Desconhecido Produto - (Lote): Kit
de teste de antígeno SARS-CoV-2 (ouro coloidal) - Autoteste (20211215 /
20220515); Tipo de Produto: Produtos para Saúde (Correlatos) Expediente nº:
0328527/24-8 Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização: Proibição - Comercialização, Distribuição, Fabricação,
Importação, Propaganda, Uso Motivação: Considerando que a empresa denunciante
evidenciou a compra do "Kit de teste de antígeno SARS-CoV-2 (Ouro Coloidal)
- Autoteste", registrado sob número 81666770004, lote 20211215, sub lote
20220515, contendo prazo de validade estendido, sem autorização da Anvisa,
com fabricação em 15/05/2022 e validade até 14/11/2024, tratando-se,
portanto, de adulteração, conforme o art. 7º da Lei n. 6.360/1976, o art. 7º,
inciso XV da Lei nº 9.782/1999 e em desacordo com o art. 10, inciso XXVIII da
Lei nº. 6.437/1977.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">Resolução-RE
nº 1.081, de 19 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: Bioline Indústria e Distribuidora de Cosméticos Ltda
- CNPJ: 27091984000110 Produto - (Lote): SABONETE LÍQUIDO SEM ENXÁGUE ECO
SKIN(TODOS); Tipo de Produto: Cosmético Expediente nº: 0340842/24-6 Assunto:
70358 - Revogação de Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização revogadas: Recolhimento Suspensão - Comercialização,
Distribuição, Fabricação, Propaganda, Uso Motivação: Considerando o relatório
de inspeção da VISA/SP, FICHA DE PROCEDIMENTOS No.01.000031/24, datado de
22/02/2024 a 23/02/2024. Consta no relatório, dentre outras evidências, a
seguinte consideração: Considerando a avaliação pela equipe inspetora das
evidências de adequação visando a liberação do estabelecimento para
fabricação de produtos que contenham água como matéria-prima em sua
formulação, exigidas em Ficha de Procedimentos nº 01.000013/24, bem como do
Plano de Ação proposto pelo estabelecimento quanto às demais não
conformidades (NC's) apontadas, a equipe inspetora apresentou parecer
favorável, conforme item 2 deste relatório de inspeção, consentindo assim
pela liberação de venda e fabricação de produtos que contenham água como
matéria-prima em sua formulação, fabricados pelo estabelecimento BIOLINE
INDÚSTRIA E DISTRIBUIDORA DE COSMÉTICOS LTDA, CNPJ 27.091.984/0001-10<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">1.071</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=119&totalArquivos=164">1.072</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=120&totalArquivos=164">1.073</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=120&totalArquivos=164">1.074</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=128&totalArquivos=164">1.079</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=120&totalArquivos=164">1.075</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=121&totalArquivos=164">1.076</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=127&totalArquivos=164">1.077</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=20/03/2024&jornal=515&pagina=127&totalArquivos=164">1.078</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-75607477869095688552024-03-19T09:17:00.000-03:002024-03-19T09:17:04.384-03:00CLIPPING CRF/RS 19/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/diretoria--do--crf-rs--marca--presenca--na--mega--feira--2024--promovida--pela--rede--agafarma">DIRETORIA
DO CRF-RS MARCA PRESENÇA NA MEGA FEIRA 2024 PROMOVIDA PELA REDE AGAFARMA</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/18/03/2024/sp-policia-prende-grupo-acusado-de-roubar-farmacias">SP:
Polícia prende grupo acusado de roubar farmácias</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/18/03/2024/patrono-da-farmacia-clinica-no-brasil-cff-lamenta-o-falecimento-de-jose-aleixo-prates-e-silva">Patrono
da Farmácia Clínica no Brasil: CFF lamenta o falecimento de José Aleixo
Prates e Silva</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/18/03/2024/projeto-determina-a-realizacao-de-campanhas-permanentes-para-a-conscientizacao-sobre-a-automedicacao">Projeto
determina a realização de campanhas permanentes para a conscientização sobre
a automedicação</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/18/03/2024/primeiro-medicamento-no-mundo-para-forma-grave-de-doenca-hepatica-gordurosa-e-aprovado-pela-fda">Primeiro
medicamento no mundo para forma grave de doença hepática gordurosa é aprovado
pela FDA</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/rs-recebe-480-mil-doses-de-vacinas-contra-a-gripe-para-dar-inicio-a-estrategia-de-imunizacao">RS
recebe 480 mil doses de vacinas contra a gripe para dar início à estratégia
de imunização</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/hemocentro-comemora-41-anos-com-mobilizacao-de-doadores-e-atividade-cultural">Hemocentro
comemora 41 anos com mobilização de doadores e atividade cultural</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinar-aborda-investigacao-de-eventos-adversos-em-servicos-de-saude">Webinar
aborda investigação de eventos adversos em serviços de saúde</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/3a-reuniao-publica-de-2024-da-dicol-acontece-nesta-terca-feira-19-3">3ª
Reunião Pública de 2024 da Dicol acontece nesta terça-feira (19/3)</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinar-tem-como-tema-importacao-de-cosmeticos-e-saneantes">Webinar
tem como tema importação de cosméticos e saneantes</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=82&totalArquivos=100">1.063</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=93&totalArquivos=100">1.068</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=83&totalArquivos=100">1.064</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=89&totalArquivos=100">1.065</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=93&totalArquivos=100">1.066</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=19/03/2024&jornal=515&pagina=93&totalArquivos=100">1.067</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-19&pg=121">Protocolo:
2024000974974</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de RETINÓIDES (LISTA “C2”), Portaria SVS/MS
344/98, os estabelecimentos constantes da seguinte relação: Razão Social:
Bonfada & Bonfada Comércio de Medicamentos Ltda- ME Endereço: Rua Sete de
Setembro, 888 Centro Cachoeira do Sul CGC/CNPJ: 15.142.774/0001-24 Processo
nº: 24/2000-0035710-7</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-75069017370351617692024-03-18T16:26:00.003-03:002024-03-18T16:26:23.782-03:00CONCURSOS PARA FARMACÊUTICO<p> </p><google-sheets-html-origin><table border="1" cellpadding="0" cellspacing="0" data-sheets-root="1" dir="ltr" style="border-collapse: collapse; border: none; font-family: Arial; font-size: 10pt; table-layout: fixed; width: 0px;" xmlns="http://www.w3.org/1999/xhtml"><colgroup><col width="347"></col></colgroup><tbody><tr style="height: 21px;"><td data-sheets-value="{"1":2,"2":"CONCURSO"}" style="border: 1px solid rgb(0, 0, 0); color: red; font-family: Calibri; font-weight: bold; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-align: center; vertical-align: bottom;">CONCURSO</td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://concursos-publicacoes.s3.amazonaws.com/888/publico/edital_abertura/edital_1_65f4b6f3ecfd3.pdf?id=65f893f68ba69" data-sheets-value="{"1":2,"2":"Itaara"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://concursos-publicacoes.s3.amazonaws.com/888/publico/edital_abertura/edital_1_65f4b6f3ecfd3.pdf?id=65f893f68ba69" target="_blank">Itaara</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://concursos-publicacoes.s3.amazonaws.com/877/publico/edital_abertura/edital_1_65f497835a4de.pdf?id=65f893a0169ad" data-sheets-value="{"1":2,"2":"Cidreira"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://concursos-publicacoes.s3.amazonaws.com/877/publico/edital_abertura/edital_1_65f497835a4de.pdf?id=65f893a0169ad" target="_blank">Cidreira</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://concursos-publicacoes.s3.amazonaws.com/889/publico/edital_abertura/edital_abertura_88965f831705f30e.pdf?id=65f89352c8d59" data-sheets-value="{"1":2,"2":"Arroio do Sal"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://concursos-publicacoes.s3.amazonaws.com/889/publico/edital_abertura/edital_abertura_88965f831705f30e.pdf?id=65f89352c8d59" target="_blank">Arroio do Sal</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://arquivos-site.avalia.org.br/publicacoes/a264b296-0cbb-4a61-a6a4-2eed9079c873.pdf" data-sheets-value="{"1":2,"2":"Fundação Hospitalar Getúlio Vargas de Tramandaí (FHGV)"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://arquivos-site.avalia.org.br/publicacoes/a264b296-0cbb-4a61-a6a4-2eed9079c873.pdf" target="_blank">Fundação Hospitalar Getúlio Vargas de Tramandaí (FHGV)</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://arquivos-site.avalia.org.br/publicacoes/b8891c27-6890-4d0d-abc1-1bfe2195be55.pdf" data-sheets-value="{"1":2,"2":"Fundação Hospitalar Getúlio Vargas - FHGV"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://arquivos-site.avalia.org.br/publicacoes/b8891c27-6890-4d0d-abc1-1bfe2195be55.pdf" target="_blank">Fundação Hospitalar Getúlio Vargas - FHGV</a></td></tr></tbody></table></google-sheets-html-origin>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-22012332269530300982024-03-18T11:47:00.001-03:002024-03-18T11:47:16.750-03:00CLIPPING CRF/RS 18/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
anvisa, ses/rs, crf/rs, cff, ms<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; margin-left: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/15/03/2024/farmaceutica-deve-perder-patente-e-venvanse-pode-ganhar-versao-generica-e-mais-barata">Farmacêutica
deve perder patente e venvanse pode ganhar versão genérica e mais barata</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; margin-left: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/15/03/2024/cff-define-data-para-o-i-forum-nacional-da-assistencia-farmaceutica-na-saude-indigena">CFF
define data para o I fórum nacional da assistência farmacêutica na saúde
indígena</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; margin-left: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/15/03/2024/ministerio-da-saude-incorpora-medicamento-inovador-para-malaria-ao-sus">Ministério
da saúde incorpora medicamento inovador para malária ao sus</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; margin-left: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/saude-da-mulher-lanca-boletim-epidemiologico-do-cancer-de-colo-de-utero-no-rs">Saúde
da mulher lança boletim epidemiológico do câncer de colo de útero no rs</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; margin: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinarda-anvisa-ira-abordar-procedimentos-para-importacao-de-alimentos">Webinar da
anvisa irá abordar procedimentos para importação de alimentos</a> <o:p></o:p></span></span></h1>
<h1 style="background: white; margin: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p><span style="text-decoration: none;"> </span></o:p></span></span></h1>
<h1 style="background: white; margin: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/certificado-internacional-de-vacinacao-e-tema-de-webinar">Certificado
internacional de vacinação é tema de webinar</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; margin-left: 0cm; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/rio-grande-sul-762-mil-absorventes-sao-distribuidos-para-20-5-mil-gauchas">Rio
grande do sul: 762 mil absorventes são distribuídos para 20,5 mil gaúchas</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos normativos dou - presidência/ministério da
saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=70&totalArquivos=133">Portaria
GM/MS nº 3.260, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a portaria gm/ms nº 3.318 de 22 de agosto de 2022, que
estabelece os limites de tolerância ao risco para análise informatizada de
prestação de contas de convênios apresentadas a partir de 1º de setembro de
2018.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=71&totalArquivos=133">Portaria
SE/MS nº 430, de 15 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre a prorrogação de prazo para manifestação de
interesse dos entes federativos, previsto no art. 5º da portaria gm/ms nº
3.084/2024, que dispõe sobre as repactuações entre o ministério da saúde e os
entes federativos e a reativação de obras ou serviços de engenharia
destinados à saúde no âmbito do pacto nacional pela retomada de obras e de
serviços de engenharia destinados à educação básica e profissionalizante e à
saúde.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo dou - recolhimentos/suspensão de produtos/consultas públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=120&totalArquivos=133">Resolução-RE
nº 1.055, de 15 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: controller comércio e serviços ltda - cnpj:
78.515.210/0001-00 produto - (lote): monitor de glicose bioland g-500 (22i);
tipo de produto: produtos para saúde (correlatos) expediente nº: 0296656/24-5
assunto: 70351 - ações de fiscalização em vigilância sanitária ações de
fiscalização: recolhimento suspensão - comercialização, distribuição, uso
motivação: considerando o laudo de análise fiscal n.º 3410.cp.1/2023, tornado
condenatório em razão resultado da perícia de contraprova, emitido pelo instituto
nacional de controle de qualidade em saúde, que apresentou resultado
insatisfatório no ensaio de análise de conformidade, para o lote nº 22i do
bioland monitor de glicose, mod. G-500, em desacordo com o art. 15, §1º e
art. 17 do decreto nº. 8.077/2013; e considerando o estabelecido no art. 7º.
Da lei 6360/1976 e no art. 10, incisos iv, xxix e xxxv da lei nº. 6.437/1977<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=120&totalArquivos=133">Resolução-RE
nº 1.061, de 15 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: farma saluti ltda - cnpj: 39.897.260/0001-47 produto
- apresentação (lote): produtos manipulados (lotes: n/a); tipo de produto:
medicamento expediente nº: 0287025/24-8 assunto: 70351 - ações de
fiscalização em vigilância sanitária ações de fiscalização: suspensão -
propaganda motivação: comprovação da exposição de produto manipulado ao
público por meio do site https://www.farmasaluti.com.br/,em desacordo com o
item 5.14 do anexo - regulamento técnico que institui as boas práticas de
manipulação em farmácias (bpmf) da rdc nº 67/2007. Esta medida preventiva
está fundamentada no art. 7º da lei nº 6.360/1976.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=121&totalArquivos=133">Resolução-RE
nº 1.062, de 15 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: trl internacional, importadora e exportadora ltda -
cnpj: 14546348000193 produto - (lote): azeite de oliva extra virgem marca
vincenzo (19227 095); tipo de produto: alimento expediente nº: 0325247/24-7
assunto: 70351 - ações de fiscalização em vigilância sanitária ações de
fiscalização: recolhimento suspensão - comercialização, distribuição,
propaganda, uso motivação: considerando o resultado insatisfatório no ensaio
de determinação do índice de refração e do índice de iodo wijs, conforme laudo
de análise fiscal definitivo nº 648.1p.0/2023, emitido pelo laboratório
central de saúde pública noel nutels - lacen /rj, infringindo: inciso iv do
art. 48 do decreto lei n. 986/1969; resolução - rdc nº 727/2022; resolução -
rdc nº 481/2021 e instrução normativa mapa nº 1, de 30/01/2012; tendo em
vista o inciso xv, art. 7º da lei nº 9.782, de 26 de janeiro de 1999<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo dou - anvisa – decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ae de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">empresas de medicamentos e de insumos farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=121&totalArquivos=133">1.054</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=125&totalArquivos=133">1.060</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Afe de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=121&totalArquivos=133">1.056</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=123&totalArquivos=133">1.057</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=125&totalArquivos=133">1.058</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=125&totalArquivos=133">1.059</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=125&totalArquivos=133">1.045</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=126&totalArquivos=133">1.047</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de boas práticas de distribuição e/ou armazenagem.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">998</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">999</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=119&totalArquivos=133">1.050</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de boas práticas de fabricação.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=117&totalArquivos=133">986</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=117&totalArquivos=133">987</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">994</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">995</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">1.000</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">1.001</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=118&totalArquivos=133">1.048</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=119&totalArquivos=133">1.049</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=119&totalArquivos=133">1.051</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=119&totalArquivos=133">1.052</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=120&totalArquivos=133">1.053</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à gerência geral de alimentos.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=73&totalArquivos=133">996</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=73&totalArquivos=133">997</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à gerência geral de medicamentos e produtos biológicos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=74&totalArquivos=133">1.023</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=74&totalArquivos=133">1.024</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=75&totalArquivos=133">1.025</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=76&totalArquivos=133">1.026</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=76&totalArquivos=133">1.027</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=76&totalArquivos=133">1.028</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à gerência geral de tecnologia de produtos
para a saúde.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=104&totalArquivos=133">1.013</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=106&totalArquivos=133">1.014</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=109&totalArquivos=133">1.015</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=110&totalArquivos=133">1.016</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=111&totalArquivos=133">1.017</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 8;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à gerência-geral de produtos biológicos, radiofármacos,
sangue, tecidos, células, órgãos e produtos de terapias avançadas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=77&totalArquivos=133">1.009</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=78&totalArquivos=133">1.041</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 9;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registro ou notificação de produtos para a saúde, cancelamento<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=79&totalArquivos=133">1.020</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=113&totalArquivos=133">1.018</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=114&totalArquivos=133">1.019</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 10;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registros e petições <span style="color: black;">à gerência geral
de produtos de higiene, perfumes, cosméticos e saneantes.</span><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=115&totalArquivos=133">1.022</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=116&totalArquivos=133">1.030</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=116&totalArquivos=133">1.031</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=116&totalArquivos=133">1.033</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=116&totalArquivos=133">1.034</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 11;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Resoluções, insubsistência.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=114&totalArquivos=133">1.021</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 12; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="margin-left: 0cm; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Resoluções,
retificações, prorrogações.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=77&totalArquivos=133">1.010</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/03/2024&jornal=515&pagina=78&totalArquivos=133">1.011</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - doe/rs</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-18&pg=152">Portaria
SES nº 178/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Altera a portaria ses nº 45, de 19 de
janeiro de 2022, que habilita os hospitais prestadores de serviços ao sus ao
recebimento dos recursos financeiros do assistir - programa de incentivos
hospitalares, conforme decreto n° 56.015, de 02 de agosto de 2021, e portaria
ses nº 537, de 03 de agosto de 2021. Proa nº 24/2000-0030060-1.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-18&pg=153">Portaria
SES nº 182/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Altera a portaria ses nº 639, de 14 de
setembro de 2021, que habilita os hospitais prestadores de serviços ao sus ao
recebimento dos recursos financeiros do assistir - programa de incentivos
hospitalares. Proa nº 24/2000-0029993-0</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-18&pg=154">Portaria
SES nº 183/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Altera a portaria ses nº 639, de 14 de
setembro de 2021, que habilita os hospitais prestadores de serviços ao sus ao
recebimento dos recursos financeiros do assistir - programa de incentivos
hospitalares. Proa nº 24/2000-0029951-4.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-18&pg=155">Portaria
SES nº 184/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Altera a portaria ses nº 639, de 14 de
setembro de 2021, que habilita os hospitais prestadores de serviços ao sus ao
recebimento dos recursos financeiros do assistir - programa de incentivos
hospitalares. Proa nº 24/2000-0029983-2.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-69863900774637502412024-03-15T09:16:00.001-03:002024-03-15T09:16:10.040-03:00CLIPPING CRF/RS 15/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-e-pnud-selecionam-consultores-para-a-farmacopeia">Anvisa
e PNUD selecionam consultores para a Farmacopeia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/participe-da-consulta-dirigida-sobre-autorizacao-de-funcionamento-e-boas-praticas-de-armazenagem">Participe
da consulta dirigida sobre autorização de funcionamento e boas práticas de
armazenagem</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/inspecao-nova-versao-do-pop-o-snvs-014-entrara-em-vigor-no-dia-6-de-maio">Inspeção:
nova versão do POP-O-SNVS-014 entrará em vigor no dia 6 de maio</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/oito-municipios-gauchos-participam-do-estudo-para-analisar-sequelas-da-covid-19">Oito
municípios gaúchos participam do estudo para analisar sequelas da Covid-19</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=118&totalArquivos=163">Portaria
GM/MS nº 3.121, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Institui, no âmbito do Ministério da Saúde, Grupo de Trabalho
para Controle e Eliminação do Câncer do Colo do Útero.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=118&totalArquivos=163">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">GM/MS </span>nº 3.147, de 11 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Aprova a adesão de entes federativos à Política Nacional de
Atenção Integral à Saúde das Pessoas Privadas de Liberdade no Sistema
Prisional (PNAISP) no âmbito do Sistema Único de Saúde (SUS)<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 991, de 14 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: EMPRESA DESCONHECIDA Produto - (Lote): NOVEL
CORONAVÍRUS (2019-NCOV) ANTIGEN RAPID TEST (20220104, com validade
20/01/2025); NOVEL CORONAVÍRUS (COVID-19) AUTOTESTE ANTÍGENO (20220105, com
validade 16/10/2024); NOVEL CORONAVÍRUS (COVID-19) AUTOTES T E ANTÍGENO
(20220104, com validade 16/10/2024); Tipo de Produto: Produtos para Saúde
(Correlatos) Expediente nº: 0298305/24-2 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Proibição -
Comercialização, Distribuição, Fabricação, Importação, Propaganda, Uso
Motivação: Considerando que a detentora do registro e importadora dos
produtos Novel Coronavírus (Covid-19) Autoteste Antígeno (registro n.
80859840213) e Novel Coronavírus (2019-nCoV) Antigen Rapid Test (registro n.
80859840211), identificou no mercado unidades destes produtos com
características divergentes do original (para o produto Novel Coronavírus
(Covid-19) Autoteste Antígeno: i) lote e validade na embalagem secundária:
20220104 e 16/10/2024; lote e validade no cassete de testes: 0220105 e
27/07/2023; ii) lote e validade na embalagem secundária: 20220105 e
16/10/2024; lote e validade no cassete de testes: 0220105 e 27/07/2023. Para
o produto Novel Coronavírus (2019-nCoV) Antigen Rapid Test: lote e validade na
embalagem secundária: 20220104 e 20/01/2025; lote e validade no cassete de
testes: 0220105 e 27/07/2023), tratando-se, portanto, de adulteração,
conforme o art. 7º da Lei n. 6.360/1976, o art. 7º, inciso XV da Lei nº
9.782/1999 e em desacordo com o art. 10, inciso XXVIII da Lei nº. 6.437/1977.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 992, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: CONTROLLER COMÉRCIO E SERVIÇOS LTDA - CNPJ:
78.515.210/0001-00 Produto - (Lote): MONITOR DE GLICOSE BIOLAND G-500 (22I);
Tipo de Produto: Produtos para Saúde (Correlatos) Expediente nº: 0296432/24-5
Assunto: 70358 - Revogação de Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização revogadas: Interdição cautelar Motivação: Considerando
a realização da perícia de contraprova, realizada no período de 05 a
07/03/2024, no Instituto Nacional de Controle de Qualidade-INCQS/FIOCRUZ,
para o lote B23A101A12A da FITA DE TESTE DE GLICOSE BIOLAND (Laudo n
3408.CP.0/2023, com conclusão satisfatória) e para o lote nº 22I do BIOLAND
MONITOR DE GLICOSE, MOD. G-500 (Laudo n 3410.CP.1/2023 que apontou resultado
insatisfatório no ensaio de análise de conformidade) e considerando o
estabelecido o estabelecido no Art. 23 e Art. 27 da lei nº 6.437, de 20 de
agosto de 1977<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 993, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: CONTROLLER COMÉRCIO E SERVIÇOS LTDA - CNPJ:
78.515.210/0001-00 Produto - (Lote): MONITOR DE GLICOSE BIOLAND G-500 (22I);
Tipo de Produto: Produtos para Saúde (Correlatos) Expediente nº: 0296469/24-4
Assunto: 70358 - Revogação de Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização revogadas: Recolhimento Suspensão - Comercialização,
Distribuição, Importação, Uso Motivação: Considerando a realização da perícia
de contraprova, realizada no período de 05 a 07/03/2024, no Instituto Nacional
de Controle de Qualidade-INCQS/FIOCRUZ, para o lote B23A101A12A da FITA DE
TESTE DE GLICOSE BIOLAND (Laudo n 3408.CP.0/2023, com conclusão satisfatória)
e para o lote nº 22I do BIOLAND MONITOR DE GLICOSE, MOD. G-500 (Laudo n
3410.CP.1/2023 que apontou resultado insatisfatório no ensaio de análise de
conformidade) e considerando o estabelecido o estabelecido no Art. 23 e Art.
27 da lei nº 6.437, de 20 de agosto de 1977<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 1.032, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: INDUSTRIA E COMERCIO DE ALIMENTOS SUPREMO LTDA - CNPJ:
03080479000101 Produto - (Lote): CARNE MOÍDA CONGELADA DE BOVINO MARCA
SUPREMO CARNES SIF 3845 (lote 220224); Tipo de Produto: Alimento Expediente
nº: 0318680/24-6 Assunto: 70351 - Ações de Fiscalização em Vigilância
Sanitária Ações de fiscalização: Proibição - Comercialização, Distribuição,
Uso Recolhimento - Voluntário Motivação: Considerando o comunicado de
recolhimento voluntário recebido da empresa INDUSTRIA E COMERCIO DE ALIMENTOS
SUPREMO LTDA, referente ao produto CARNE MOÍDA CONGELADA DE BOVINO, marca
SUPREMO CARNES, fabricado na unidade de Ibirité - MG (SIF 3845), lote 220224,
produção 22/02/2024, prazo de validade 21/02/2025, apresentado em embalagem
plástica à vácuo com conteúdo líquido de 1 kg, devido a resultados analíticos
acima dos limites estabelecidos no padrão microbiológico do produto (ensaio
de mesófilos viáveis e Esherichia coli), tendo em vista o inciso XV, art. 7º
da Lei nº 9.782, de 26 de janeiro de 1999 e o art. 8º da Resolução da
Diretoria Colegiada-RDC nº 655, de 24 de março de 2022). Foram infringidos:
item 6 do anexo I da IN 161/2022; incisos VIII e XIV do art. 3º e art. 4º da
RDC 724/2022; art. 48 do Decreto-Lei 986/1969<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 1.035, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: ALEXDAN IMPORTAÇÃO E EXPORTAÇÃO LTDA - EPP - CNPJ:
03.098.281/0001-55 Produto - (Lote): Família de Teste HCG em Tira (LOTES A
PARTIR DE 01/01/2020); Família Teste de Fertilidade Midstream (LOTES A PARTIR
DE 01/01/2020); Família Teste de Gravidez de Sangue (LOTES A PARTIR DE
01/01/2020); Família Teste de Menopausa (LOTES A PARTIR DE 01/01/2020);
Família Teste de Reserva Ovariana (LOTES A PARTIR DE 01/01/2020); Família
Teste de Vitamina D (LOTES A PARTIR DE 01/01/2020); Família Teste de Vitamina
D Profissional (LOTES A PARTIR DE 01/01/2020); Tipo de Produto: Produtos para
diagnóstico de uso in vitro Expediente nº: 0302579/24-9 Assunto: 70351 -
Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Recolhimento Suspensão - Comercialização, Distribuição, Fabricação,
Importação, Propaganda, Uso Motivação: Considerando a comprovação da
fabricação, importação, comercialização e divulgação, por prestação de
informações falsas quanto ao fabricante legal e unidade fabril e considerando
o risco sanitário associado a comercialização de produtos sem garantia da
qualidade e segurança, em desacordo com o Art. 64 da RDC nº. 665/2022, art.
15, §1º e art. 17 do Decreto nº. 8.077/2013; e considerando o estabelecido no
art. 7º. da Lei 6360/1976 e no art. 10, incisos IV, XXIX e XXXV da Lei nº.
6.437/1977<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">Resolução-RE
nº 1.036, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote):
POMADA PARA CABELOS FEATHERWEIGHT UPPERCUT(TODOS);POMA DA PARA CABELOS SHINE
EFFECT LINHA JOHN LEVISK(TODOS);POMADA PARA CABELOS MATTE EFFECT LINHA JOHN
LEVISK,(TODOS);POMADA PARA CABELOS FIRME POMADE(TODOS);POMADA PARA CABELOS
SHINE POMADE(TODOS); Tipo de Produto: Cosmético Expediente nº: 0314743/24-6
Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização: Apreensão Proibição - Comercialização, Distribuição, Fabricação,
Importação, Propaganda, Uso Motivação: Considerando a exposição à venda do
produto sem registro infringindo o art. 12 da Lei 6360, de 23 de setembro de
1976 e tendo em vista o previsto nos art 6º e inciso I do art. 67 da Lei
6360, de 23 de setembro de 1976 e inciso XV do art. 7º da Lei 9782, de 26 de
janeiro de 1999. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: M.B.C. INDUSTRIA DE COSMETICOS LTDA - CNPJ:
23231422000173 Produto - (Lote): PASTA MODELADORA BLACK - THE DODGER(TODOS);
Tipo de Produto: Cosmético Expediente nº: 0315301/24-1 Assunto: 70351 - Ações
de Fiscalização em Vigilância Sanitária Ações de fiscalização: Recolhimento
Suspensão - Comercialização, Distribuição, Fabricação, Propaganda, Uso
Motivação: Considerando a composição do produto declarada na rotulagem
divergente da fórmula declarada pela empresa no processo de regularização,
descumprindo o disposto rt. 11; art. 13, II, "i"; art. 14, da RDC
752/2022, e tendo em vista o previsto nos arts 6º, 7º e inciso III do art. 63
da Lei 6.360, de 23 de setembro de 1976. .........................................
<o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">3. Empresa: DNA COSMETICS INDÚSTRIA E COMÉRCIO LTDA - CNPJ:
27661501000175 Produto - (Lote): MODELADOR CAPILAR(TODOS);POMADA MEDIUM OIL -
CABALLEROS(TODOS);STRONG MATTE POMADE - CABALLEROS(TODOS); Tipo de Produto:
Cosmético Expediente nº: 0314751/24-7 Assunto: 70351 - Ações de Fiscalização
em Vigilância Sanitária Ações de fiscalização: Recolhimento Suspensão -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando à exposição à venda de produto cosmético rotulado com o ingrediente
CANNABINOID ACTIVE infringindo o item 306 da Resolução 529, de 4 de agosto de
2021 e o art. 5º da Lei n.º 6.360, de 23 de setembro de 1976 e tendo em vista
o previsto no art. 6º e inciso I do art. 67 da Lei n.º 6.360, de 23 de
setembro de 1976. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">4. Empresa: SUL BR INDUSTRIA COMERCIO IMPORTACAO E EXPORTACAO DE
COSMETICOS LTDA - CNPJ: 32998509000161 Produto - (Lote): CREME MODELADOR TEIA
YELSEW(TODOS);CREME MODELADOR MAÇA VERDE YELSE(TODOS);CREME MODELADOR BLACK
YELSEW(TODOS);CREME MODELADOR MATTE YELSEW(TODOS);CREME MODELADOR UVA
YELSEW(TODOS);CREME MODELADOR EXTRA FORTE YELSEW(TODOS); Tipo de Produto:
Cosmético Expediente nº: 0314726/24-6 Assunto: 70351 - Ações de Fiscalização
em Vigilância Sanitária Ações de fiscalização: Recolhimento Suspensão - Comercialização,
Distribuição, Fabricação, Propaganda, Uso Motivação: Considerando a
comprovação da fabricação de produto cosmético, higiene pessoal ou perfume
com fórmula diferente da autorizada pela Anvisa e tendo em vista o previsto
nos arts 6º, 7º e inciso III do art. 63 da Lei 6360, de 23 de setembro de
1976. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">5. Empresa: DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote):
SIÔUX HARD GEL QUE CONTENHA A FRASE "MADE IN PCR" E ROTULAGEM
ESCRITA EM INGLÊS(TODOS); Tipo de Produto: Cosmético Expediente nº:
0304325/24-8 Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização: Apreensão Proibição - Comercialização, Distribuição,
Fabricação, Importação, Propaganda, Uso Motivação: Considerando a exposição à
venda do produto sem registro por empresa sem autorização de funcionamento
para a fabricação infringindo os arts. 2º e 12 da Lei 6360, de 23 de setembro
de 1976 e tendo em vista o previsto nos art 6º e inciso I do art. 67 da Lei
6360, de 23 de setembro de 1976 e inciso XV do art. 7º da Lei 9782, de 26 de
janeiro de 1999<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=136&totalArquivos=163">Resolução-RE
nº 1.007, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: EMPRESA DESCONHECIDA. Produto - (Lote): ESTETOSCÓPIO 3M
LITTMANN CLASSIC (Série: J16D968929, Modelo 5620); Tipo de Produto: Produtos
para Saúde (Correlatos) Expediente nº: 0303469/24-1 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Proibição -
Comercialização, Distribuição, Fabricação, Importação, Propaganda, Uso
Motivação: Considerando que a detentora do registro e importadora do produto
Estetoscópio 3M Littmann (cadastro 80284930338) identificou no mercado unidades
desse produto com características divergentes dos produtos originais, somente
verificadas após desmonte do produto em assistência técnica especializada,
tratando-se, portanto, de falsificação, conforme o art. 7º da Lei n.
6.360/1976, o art. 7º, inciso XV da Lei n. 9.782/1999 e em desacordo com o
art. 10, inciso XXVIII da Lei n. 6.437/1977<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 8; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=136&totalArquivos=163">Resolução-RE
nº 1.012, de 14 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: GABRIEL LUIZ ANJOS DE MATOS 16522090694 - CNPJ:
39571912000159 Produto - (Lote): SUPLEMENTO ALIMENTAR LÍQUIDO CONTENDO
LUTEÍNA, ZEAXANTINA E ASTAXANTINA, MARCA SULIMAX (TODOS); Tipo de Produto:
Alimento Expediente nº: 0314915/24-3 Assunto: 70351 - Ações de Fiscalização
em Vigilância Sanitária Ações de fiscalização: Suspensão - Propaganda
Motivação: Considerando a realização de indicações terapêuticas, alegações
funcionais e de saúde não aprovadas e enganosas, em propagandas do Suplemento
alimentar líquido contendo luteína, zeaxantina e astaxantina, marca Sulimax,
no site https://sulimaxoriginal.online/sulimax/, tais como nos exemplos a
seguir: "regular a pressão dos olhos"; "prevenir doenças
oculares"; "prevenir problemas oculares, incluindo a degeneração
macular relacionada à idade"; "prevenir problemas como degeneração
da retina e catarata"; "prevenir danos celulares, reduzir o risco
de problemas oculares". Os sites e alegações mencionadas são meros
exemplos, logo, as medidas preventivas aqui dispostas se aplicam a todos
produtos similares e ambientes de divulgação sob responsabilidade da empresa
responsável. Foram infringidos os seguintes dispositivos legais: Arts. 21 e
22, com base no 23 do Decreto Lei n. 986, de 21 de outubro de 1969; Art. 4.3
da Resolução n. 16, de 30 de abril de 1999; Item 3.4 da Resolução n. 18, de
30 de abril de 1999; art. 16 e incisos I, II e IV do art. 17 da RDC n. 243,
de 26 de julho de 2018; art. 9 e Anexo V da Instrução Normativa - IN nº 28,
de 26 de julho de 2018; e incisos I, II, VI, VII e VII do art. 4 da Resolução
RDC nº 727, de de 1° de julho de 2022, tendo em vista o inciso XXVI do art.
7º da Lei nº 9.782, de 26 de janeiro de 1999.
......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: CAPSUL BRASIL INDUSTRIA E COMERCIO S.A. - CNPJ:
29822523000103 Produto - (Lote): SUPLEMENTO ALIMENTAR EM CÁPSULAS DA MARCA
ANTOCIONIDINOL (TODOS); Tipo de Produto: Alimento Expediente nº: 0314968/24-4
Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização: Recolhimento Suspensão - Comercialização, Distribuição,
Fabricação, Propaganda, Uso Motivação: Considerando fabricação e
comercialização dos produtos com ingredientes não avaliados para segurança de
uso em alimentos, além de indicações terapêuticas, alegações funcionais e de
saúde não aprovadas e enganosas em propagandas do Suplemento Alimentar
ANTOCIODINOL, no site https://antocionidinol.com, tais como: "combater
os sintomas de próstata e a hiperplasia prostática benigna";
"alívio imediato, combatendo o inchaço e promovendo uma saúde
prostática"; "Auxilia na redução da inflamação da próstata";
"Trabalha na diminuição do inchaço da próstata provocado pela
hiperplasia prostática benigna...eliminar os problemas com as
hemorroidas"; "Previne doenças e infecções". Os sites e
alegações mencionadas são meros exemplos, logo, as medidas preventivas aqui
dispostas se aplicam a todos produtos similares e ambientes de divulgação sob
responsabilidade da empresa responsável. Foram infringidos os seguintes
dispositivos legais: Arts. 3, 21, 23, 28, 41, 48 do Decreto-Lei nº 986/1969;
Item 5.1 da Resolução 23/2000; os art. 4º, 8, 16 e incisos I, II e IV do
artigo 17 da RDC nº 243/2018; Anexos I e II da Instrução Normativa - IN nº
28/2018 e Incisos I, II, III, IV, V, VI, VII e VIII do art. 4 da RDC nº
727/2022; tendo em vista o inciso XV, art. 7º da Lei nº 9.782/1999 e o art.
9º da Resolução da Diretoria Colegiada-RDC nº 655/2022<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=136&totalArquivos=163">1.006</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=136&totalArquivos=163">1.008</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=132&totalArquivos=163">1.002</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=134&totalArquivos=163">1.003</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=135&totalArquivos=163">1.004</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=136&totalArquivos=163">1.005</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Fabricação.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=15/03/2024&jornal=515&pagina=131&totalArquivos=163">978</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/DeliberacaoDePlenaria-1791.2024-PF.PJ.pdf">Deliberação
de Plenária 1.791/2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Concessão de inscrição e
baixa de profissionais e registro e baixa de estabelecimentos junto ao CRF/RS.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-5509107751386593952024-03-14T09:18:00.003-03:002024-03-14T09:18:40.149-03:00CLIPPING CRF/RS 14/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/medicamentos-destinacao-comercial-a-estabelecimentos-de-saude-ou-governamental">Medicamentos:
destinação comercial, a estabelecimentos de saúde ou governamental</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/13/03/2024/participe-do-3-edicao-do-premio-autocuidado-em-saude-acessa">Participe
do 3ª edição do Prêmio Autocuidado em Saúde ACESSA</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-divulga-dados-de-producao-dos-bancos-de-tecidos">Anvisa
divulga dados de produção dos bancos de tecidos</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=67&totalArquivos=113">Portaria
GM/MS nº 3.155, de 13 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera o Anexo XVI da Portaria de Consolidação GM/MS nº 2, de 28
de setembro de 2017, para instituir o Comitê Técnico de Saúde da População em
Situação de Rua.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=68&totalArquivos=113">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">GM/MS</span> nº 3.212, de 13 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Estabelece as metas de desempenho institucionais do Departamento
Nacional de Auditoria do Sistema Único de Saúde - DENASUS referentes aos dois
ciclos do ano de 2024 para fins de pagamento da Gratificação de Desempenho de
Atividade de Execução e Apoio Técnico à Auditoria - GDASUS<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=84&totalArquivos=113">Resolução
nº 733, de 1º de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre criação do Grupo de Trabalho sobre a Política
Nacional de Atenção às Pessoas com Doenças Reumáticas (GT-REUMATO/CNS)<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="file:///C:/Users/marcia/Downloads/Clipping/1.%20Empresa:%20Bioline%20Ind%C3%BAstria%20e%20Distribuidora%20de%20Cosm%C3%A9ticos%20Ltda%20-%20CNPJ:https:/pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=93&totalArquivos=113">Resolução-RE
nº 168, de 15 de janeiro de 2024 (*)</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: Bioline Indústria e Distribuidora de Cosméticos Ltda -
CNPJ: 27091984000110 Produto - (Lote): SABONETE LÍQUIDO SEM ENXÁGUE ECO SKIN
(TODOS); Tipo de Produto: Cosmético Expediente nº: 0049173/24-0 Assunto:
70351 - Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Recolhimento Suspensão - Comercialização, Distribuição, Fabricação,
Propaganda, Uso Motivação: Considerando que o produto apresentou contaminação
microbiana e presença de patógenos, conforme Laudo de Análise nº 1695.1P.0/2023,
emitido pelo Instituto Adolfo Lutz/SP no âmbito da investigação de surto de B
cepacia no Hospital do Servidor Público Estadual de São Paulo, e considerando
que foi detectado, durante inspeção realizada em 17/11/2023, o descumprimento
da Resolução RDC nº 48, de 25 de outubro de 2013 (Regulamento Técnico de Boas
Práticas de Fabricação para Produtos de Higiene Pessoal, Cosméticos e
Perfumes), conforme Ficha de procedimento 01.000237/23, especialmente dos
requisitos relacionados ao sistema de tratamento de água e tendo em vista o
previsto nos arts 6º, 7º e inciso I do art. 67 da Lei 6360, de 23 de setembro
de 1976. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">(*) Republicada por incorreção no original publicado no DOU nº
12, de 17 de janeiro de 2024, Seção 1, página 87.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=93&totalArquivos=113">979</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=93&totalArquivos=113">980</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=97&totalArquivos=113">985</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=93&totalArquivos=113">981</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=95&totalArquivos=113">982</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=96&totalArquivos=113">983</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=97&totalArquivos=113">984</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=97&totalArquivos=113">988</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=97&totalArquivos=113">989</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=14/03/2024&jornal=515&pagina=97&totalArquivos=113">990</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-14&pg=157">Protocolo:
2024000972307</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos a base de substâncias retinóicas constantes da
lista C2-Portaria SVS/MS 344/98, o(s) seguinte(s) estabelecimento(s): Razão
Social: Silveira Lima e Rodrigues Ltda. Endereço: Rua Barão do Rio Branco, 826
– Centro – Santa Vitória do Palmar/RS. CNPJ: 03.479.564/0001-47 Processo Adm.
Eletrônico: 24/2000-0033704-1 Autorização nº.: 01/2024.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-14&pg=135">Portaria
SES nº 188/2024</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Define os critérios de habilitação do
Programa Estadual de Incentivos para a Atenção Primária à Saúde (PIAPS),
instituído pelo o Decreto Estadual nº 56.061 , 29 de agosto de 2021. PROA
23/2000-0019300-1.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-pagination: none; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 2.0cm; mso-para-margin-top: 6.0pt; text-indent: 0cm;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-28-2024-Nomeacao-Comite-Implantacao-SEI.pdf">Portaria
nº28/2024, de 13 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a criação do
Comitê de Implementação do SEI/CFF/CRF’s no CRF/RS e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-85954422894522371472024-03-13T09:05:00.003-03:002024-03-13T09:05:49.523-03:00CLIPPING CRF/RS 13/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/-marco-azul-marinho-campanha-de-conscientizacao-ao-cancer-colorretal">CAMPANHA
DE CONSCIENTIZAÇÃO AO CÂNCER COLORRETAL</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/12/03/2024/opas-lanca-ferramenta-gratuita-para-avaliacao-da-qualidade-da-prestacao-de-servicos-farmaceuticos">OPAS
lança ferramenta gratuita para avaliação da qualidade da prestação de
serviços farmacêuticos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/hemocentro-tem-programacao-especial-para-celebrar-41-aniversario">Hemocentro
tem programação especial para celebrar 41º aniversário</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/governo-do-rs-decreta-situacao-de-emergencia-devido-a-dengue">Governo
do RS decreta situação de emergência devido à dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-divulga-relatorios-de-monitoramento-de-sodio-e-acucares-em-alimentos-industrializados">Anvisa
divulga relatórios de monitoramento de sódio e açúcares em alimentos
industrializados</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-faz-pesquisa-de-satisfacao-dos-usuarios-da-central-de-atendimento">Anvisa
faz pesquisa de satisfação dos usuários da Central de Atendimento</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/testes-para-a-deteccao-do-hpv-vao-beneficiar-moradoras-do-rio-grande-do-sul">Testes
para a detecção do HPV vão beneficiar moradoras do Rio Grande do Sul</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=171&totalArquivos=225">Portaria
GM/MS nº 3.182, de 19 de fevereiro de 2024 (*)</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Portaria de Consolidação GM/MS nº 2, de 28 de setembro
de 2017, para instituir a Câmara Técnica Assessora em Atenção ao Portador de
Doença Neurológica - CTA em Atenção ao Portador de Doença Neurológica, no
âmbito do Ministério da Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=178&totalArquivos=225">Portaria
GM/MS nº 3.314, de 12 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Revoga o art. 68, do § 3º, do Anexo LXXXVI à Portaria de
Consolidação GM/MS nº 5, de 28 de setembro de 2017.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=182&totalArquivos=225">976</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=182&totalArquivos=225">977</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=179&totalArquivos=225">973</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=181&totalArquivos=225">974</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=13/03/2024&jornal=515&pagina=182&totalArquivos=225">975</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-13&pg=5">Decreto
nº 57.498, de 12 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Declara situação de emergência em saúde
pública para enfrentamento de epidemia de doença infecciosa viral (dengue) no
Estado do Rio Grande do Sul.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-13&pg=127">Protocolo:
2024000971334</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
aquisição e dispensação de medicamentos à base de substâncias RETINÓICAS,
constantes da relação C-2, Portaria SVS 344/98, o seguinte estabelecimento:
Razão Social: FARMATTANA - COMERCIO DE MEDICAMENTOS E COSMETICOS LTDA
Endereço: Av. Mostardeiros, 3051, Centro, Cidreira/RS CNPJ:
05.215.792/0053-66 PROA: 24/2000-0032411-0</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-27-2024-%20Nomear%20GTT%20de%20Educa%C3%A7%C3%A3o%20Farmac%C3%AAutica.pdf">Portaria
nº27/2024, de 12 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a alteração do
Grupo Técnico de Trabalho em Educação Farmacêutica do CRF/RS e dá outras
providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-32739241270555447682024-03-12T09:37:00.001-03:002024-03-12T09:37:06.360-03:00CLIPPING CRF/RS 12/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/11/03/2024/ministerio-da-saude-incorpora-teste-inovador-para-deteccao-do-hpv-em-mulheres">Ministério
da Saúde incorpora teste inovador para detecção do HPV em mulheres</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/11/03/2024/mulheres-respondem-por-62-dos-beneficiarios-do-farmacia-popular">Mulheres
respondem por 62% dos beneficiários do Farmácia Popular</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/11/03/2024/logistica-reversa-recolheu-mais-de-600-toneladas-de-residuos-de-medicamentos">Logística
reversa recolheu mais de 600 toneladas de resíduos de medicamentos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/inscricoes-para-as-segundas-equipes-da-rede-bem-cuidar-encerram-em-15-de-marco">Inscrições
para as segundas equipes da Rede Bem Cuidar encerram em 15 de março</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/estado-lanca-plataforma-de-auxilio-ao-atendimento-da-dengue-e-autoriza-enfermeiros-a-requisitar-exames">Estado
lança plataforma de auxílio ao atendimento da dengue e autoriza enfermeiros a
requisitar exames</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/scmed-orienta-sobre-envio-do-relatorio-de-comercializacao-de-medicamentos">SCMED
orienta sobre envio do relatório de comercialização de medicamentos</a><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/seminario-debate-a-criacao-do-memorial-da-pandemia-de-covid-19">Seminário
debate a criação do Memorial da Pandemia de Covid-19</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></h1>
<h1 style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt; vertical-align: baseline;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/publicada-2a-edicao-do-boletim-sobre-monitoramento-pos-mercado">Publicada
2ª edição do boletim sobre monitoramento pós-mercado</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; font-weight: normal; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=110&totalArquivos=190">Instrução
Normativa - IN n° 285, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Define a Lista de Medicamentos Isentos de Prescrição<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=117&totalArquivos=190">Instrução
Normativa - IN nº 286, de 8 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Instrução Normativa - IN nº 211, de 1º de março de
2023, que estabelece as funções tecnológicas, os limites máximos e as
condições de uso para os aditivos alimentares e os coadjuvantes de tecnologia
autorizados para uso em alimentos<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=173&totalArquivos=190">Resolução-RE
nº 962, de 11 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: METALCLIN HOSPITALAR COMERCIO DE ARTIGOS MEDICOS E
LOCACAO LTDA - CNPJ: 04221022000132 Produto - (Lote): CAMA MOTORIZADA MODELO
11.001 - MEDI-SAUDE (LOTES A PARTIR DE 16/10/2023); CAMA MOTORIZADA MODELO
1937 "S" (Todos); CAMA MOTORIZADA MODELO 1037 "A"
(Todos); CAMA MOTORIZADA MODELO 1032 "S" (Todos); CAMA MOTORIZADA
MODELO 1032 "CS" (Todos); CAMA MOTORIZADA MODELO 1031 "S"
(Todos); Tipo de Produto: Produtos para Saúde (Correlatos) Expediente nº:
0281230/24-4 Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária
Ações de fiscalização: Proibição - Comercialização, Distribuição, Fabricação,
Propaganda, Uso Motivação: Considerando a comprovação da fabricação,
distribuição, comercialização e divulgação dos produtos camas motorizadas por
não possuírem registro válido na Anvisa e considerando o risco sanitário
associado ao uso de produtos sem registro, em desacordo com o art. 7º do
Decreto nº. 8.077/2013; e considerando o estabelecido nos art. 7º e 12 da Lei
6.360/1976 e no art. 10, inciso IV da Lei 6.437/1977.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=173&totalArquivos=190">Resolução-RE
nº 963, de 11 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: MEDIX BRASIL LTDA - CNPJ: 10.268.780/0001-09 Produto -
(Lote): MEDIX BRASIL CATETER INTRAVENOSO (Todos); MEDIX BRASIL CAT E T E R
INTRAVENOSO (todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA (Todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA (todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA (todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA (todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA (todos); Medix Brasil Cateter Intravenoso Com Dispositivo de
Segurança (todos); MEDIX BRASIL CATETER INTRAVENOSO COM DISPOSITIVO DE
SEGURANÇA COMPLETO DA AGULHA (Todos); Medix Brasil Cateter Intravenoso
Periférico (todos); Medix Brasil Cateter Intravenoso Periférico Instant
Flashback (todos); MEDIX BRASIL CATETER IV PERIFÉRICO (todos); MEDIX BRASIL
CATETER IV PERIFÉRICO (todos); MEDIX BRASIL CATETER IV PERIFÉRICO (todos);
Tipo de Produto: Produtos para Saúde (Correlatos) Expediente nº: 0276791/24-1
Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização: Recolhimento Suspensão - Armazenamento, Comercialização,
Distribuição, Fabricação, Importação, Propaganda, Uso Motivação: Considerando
a inspeção sanitária realizada na empresa Medix do Brasil, no período de
28/11/2023 a 30/11/2023, durante a qual ficaram comprovados os desvios de
qualidade dos produtos em desacordo com os artigos 8º, 13, 14, 15, 21, 25,
28, 34, 107, 112, 115, 116, 120, 121, 122 Resolução-RDC nº. 665/2022 Art. 5º,
6º, 8º da Resolução-RDC 67/2009 e Art. 4º, 5º, da Resolução-RDC 551/2021),
considerando o estabelecido no art. 7º da Lei 6360/1976, no art. 10, inciso
XXXV da Lei nº. 6.437/1977 e no art. 15 do Decreto nº. 8.077/2013.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=178&totalArquivos=190">968</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=179&totalArquivos=190">969</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=174&totalArquivos=190">964</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=176&totalArquivos=190">965</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=178&totalArquivos=190">966</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=178&totalArquivos=190">967</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=179&totalArquivos=190">970</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registro ou notificação de produtos para a saúde, cancelamento<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=12/03/2024&jornal=515&pagina=146&totalArquivos=190">918</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-12&pg=85">Protocolo:
2024000970712</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
aquisição e dispensação de medicamentos à base de substâncias RETINÓICAS,
constantes da relação C-2, Portaria SVS 344/98, o seguinte estabelecimento:
Razão Social: Comércio de Medicamentos Brair LTDA Endereço: Rua Elpidio Gomes,
3915, Centro, Terra de Areia/RS CNPJ: 88.212.113/0984-01 PROA:
24/2000-0024430-2</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-45630290856734777172024-03-11T09:59:00.003-03:002024-03-11T09:59:36.823-03:00CONCURSOS PARA FARMACÊUTICO<p> </p><google-sheets-html-origin><table border="1" cellpadding="0" cellspacing="0" data-sheets-root="1" dir="ltr" style="border-collapse: collapse; border: none; font-family: Arial; font-size: 10pt; table-layout: fixed; width: 0px;" xmlns="http://www.w3.org/1999/xhtml"><colgroup><col width="347"></col></colgroup><tbody><tr style="height: 21px;"><td data-sheets-value="{"1":2,"2":"CONCURSO"}" style="border: 1px solid rgb(0, 0, 0); color: red; font-family: Calibri; font-weight: bold; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-align: center; vertical-align: bottom;">CONCURSO</td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://concursos-publicacoes.s3.amazonaws.com/882/publico/edital_abertura/edital_1_65e87eae28752.pdf?id=65eeffe7b798a" data-sheets-value="{"1":2,"2":"Augusto Pestana"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://concursos-publicacoes.s3.amazonaws.com/882/publico/edital_abertura/edital_1_65e87eae28752.pdf?id=65eeffe7b798a" target="_blank">Augusto Pestana</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://anexos.cdn.selecao.net.br/uploads/361/concursos/2430/anexos/ewFKnPbK22vci7Zz0l5QN6U1AtSkrQeUs3AEza11.pdf" data-sheets-value="{"1":2,"2":"Senador Salgado Filho"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://anexos.cdn.selecao.net.br/uploads/361/concursos/2430/anexos/ewFKnPbK22vci7Zz0l5QN6U1AtSkrQeUs3AEza11.pdf" target="_blank">Senador Salgado Filho</a></td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://concursos-publicacoes.s3.amazonaws.com/876/publico/edital_abertura/edital_abertura_87665eb550e8b221.pdf?id=65eeff524e9d1" data-sheets-value="{"1":2,"2":"Passo do Sobrado"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://concursos-publicacoes.s3.amazonaws.com/876/publico/edital_abertura/edital_abertura_87665eb550e8b221.pdf?id=65eeff524e9d1" target="_blank">Passo do Sobrado</a></td></tr></tbody></table></google-sheets-html-origin>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-42029024382384174582024-03-11T09:39:00.003-03:002024-03-11T09:39:52.224-03:00CLIPPING CRF/RS 11/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/08/03/2024/sus-vai-incorporar-medicamento-para-o-cuidado-de-pessoas-multiressistentes-ao-tratamento-do-hiv">SUS
vai incorporar medicamento para o cuidado de pessoas multiressistentes ao
tratamento do HIV</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/08/03/2024/pacientes-com-diabete-melito-tipo-2-tem-linha-de-tratamento-atualizada-no-sus">Pacientes
com diabete melito tipo 2 tem linha de tratamento atualizada no SUS</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/08/03/2024/impulsionada-pela-epidemia-da-dengue-venda-de-repelentes-cresce-em-15-estados-e-no-df">Impulsionada
pela epidemia da dengue, venda de repelentes cresce em 15 estados e no DF</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/08/03/2024/farmaceuticos-relatam-aumento-no-recebimento-de-receitas-ilegiveis">Farmacêuticos
relatam aumento no recebimento de receitas ilegíveis</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/10/03/2024/no-rj-receita-legivel-e-clara-agora-e-obrigacao-do-prescritor">No
RJ, receita legível e clara agora é obrigação do prescritor</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/farmacopeia-brasileira-tem-quatro-consultas-publicas-abertas-para-contribuicao">Farmacopeia
Brasileira tem quatro consultas públicas abertas para contribuição</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/seguranca-da-vacina-qdenga">Segurança
da vacina Qdenga</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=227&totalArquivos=400">Portaria
GM/MS nº 3.288, de 8 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Estabelece incentivo financeiro de custeio, de caráter
excepcional e temporário, para o desenvolvimento da Estratégia de Vacinação
nas Escolas, da Campanha Nacional de Vacinação contra a Poliomielite e do
Monitoramento das Estratégias de Vacinação no Brasil, no âmbito do Sistema
Único de Saúde - SUS, em 2024.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=332&totalArquivos=400">Resolução-RE
nº 949, de 8 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: FARMACE INDÚSTRIA QUÍMICO-FARMACÊUTICA CEARENSE LTDA
- CNPJ: 06.628.333/0001-46 Produto - Apresentação (Lote): fosfato dissódico
de dexametasona - 4 MG/ML SOL INJ IM/IV CX 100 AMP VD TRANS X 2,5 ML (LOTE:
DX23F066); Tipo de Produto: Medicamento Expediente nº: 0232454/24-7 Assunto:
70351 - Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Recolhimento - Voluntário Suspensão - Comercialização, Distribuição, Uso
Motivação: Comunicado de recolhimento voluntário iniciado pela empresa, em
razão de desvio de qualidade referente à uma ampola íntegra com presença de
corpo estranho, o que fere o artigo 4º da RDC 658/2022. Esta medida
preventiva está fundamentada no artigo 6º da Lei nº 6.360/1976 e na RDC nº
625/2022. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: Não Identificada - CNPJ: Desconhecido Produto -
Apresentação (Lote): SILENT NIGHTS (LOTES: TODOS); ALAVIDA (LOTES: TODOS);
SP6 COMPLETE (LOTES: TODOS); ENERGY ENHANCER (LOTES: TODOS); Y-AGE CARNOSINE
(LOTES: TODOS); Y-AGE AEON (LOTES: TODOS); Y-AGE GLUTATHIONE (LOTES: TODOS);
ICEWAVE (LOTES: TODOS); LIFEWAVE X49 (LOTES: TODOS); LIFEWAVE X39 (LOTES:
TODOS); Tipo de Produto: Medicamento Expediente nº: 0254436/24-9 Assunto:
70351 - Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Apreensão Proibição - Comercialização, Distribuição, Fabricação, Importação,
Propaganda, Uso Motivação: Comprovação da propaganda, anúncio de venda e
comercialização dos produtos sem registro, notificação ou cadastro na Anvisa,
fabricados por empresas desconhecidas, em desacordo com os artigos 2°, 12, 50
e 59 da Lei 6.360/1976. As ações de fiscalização determinadas se aplicam a
todos os medicamentos da marca "LI F E W AV E X39", "LIFEWAVE
X49", "ICEWAVE", "Y-AGE GLUTATHIONE", "Y-AGE
AEON", "Y-AGE CARNOSINE", "ENERGY ENHANCER",
"SP6 COMPLETE", "ALAVIDA" e "SILENT NIGHTS",
bem como a quaisquer pessoas físicas/jurídicas ou veículos de comunicação que
comercializem ou divulguem os produtos. Esta medida preventiva está
fundamentada no artigo 6° da Lei 6.360/1976 e inciso XV do artigo 7° da Lei
9.782/1999<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=332&totalArquivos=400">Resolução-RE
nº 950, de 8 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresa: SHPS TECNOLOGIA E SERVICOS LTDA. - CNPJ:
35.635.824/0001-12 Produto - (Lote): LUBRIFICANTE ÍNTIMO, EXTRA VISCOSIDADE E
ULTRA DESLIZANTE, G LUBE FIST - ÍNTIMO GEL 300ML (Todos); Tipo de Produto:
Produtos para Saúde (Correlatos) Expediente nº: 0271580/24-5 Assunto: 70351 -
Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Apreensão Proibição - Comercialização, Distribuição, Fabricação, Propaganda,
Uso Motivação: Considerando a comprovação da exposição à venda do produto G
Lube Fist - lubrificante íntimo, extra viscosidade Íntimo Gell 300mL, sem regularização
na Anvisa, por empresa que não possui autorização de funcionamento - AFE, por
meio do portal de ecommerce Shopee.com.br, em desacordo com os arts. 2º e 7º
do Decreto nº. 8.077/2013, arts. 2º, 7º, 12, 50 e 59 da Lei 6.360/1976; e
considerando o estabelecido no art. 7º. da Lei 6.360/1976 e no art. 10,
inciso IV e V da Lei 6.437/1977.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=332&totalArquivos=400">Resolução-RE
nº 959, de 8 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: VB INDÚSTRIA E COMÉRCIO DE SUPLEMENTOS ALIMENTARES -
CNPJ: 29255923000257 Produto - (Lote): SUPLEMENTO ALIMENTAR DE MAGNESIO EM
CAPSULAS, MARCA MAGNESIO L-TREONATO MARCA NUTRITION ALL (MAGT-NA01,
MAGT-NA02, MAGT-NA03, MAGT-NA04 e MAGT-NA05); Tipo de Produto: Alimento
Expediente nº: 0287282/24-0 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Proibição - Comercialização,
Distribuição, Uso Recolhimento - Voluntário Motivação: Considerando o
comunicado de recolhimento voluntário recebido da empresa V B INDUSTRIA E
COMERCIO DE SUPLEMENTOS NUTRICIONAIS LTDA (nome fantasia: VB INDUSTRIAL),
referente ao produto "suplemento alimentar de magnésio em cápsulas -
Magnésio L-Treonato", marca Nutrition All, lotes MAGT-NA01 (val.
05/10/2025), MAGTNA02 (val. 25/10/2025), MAGT-NA03 (val. 09/11/2025),
MAGT-NA04 (val. 09/11/2025) e MAGT-NA05 (val. 26/01/2026), devido à
composição irregular contendo constituinte não previsto para a categoria do
produto (novo ingrediente magnésio L-treonato sem avaliação da segurança de
uso), tendo em vista o inciso XV, art. 7º da Lei nº 9.782, de 26 de janeiro
de 1999 e o art. 8º da Resolução da Diretoria Colegiada-RDC nº 655, de 24 de
março de 2022). Portanto, a empresa infringi o art. 4º da Resolução RDC n.
243, de 26 de julho de 2018, anexos I e II da Instrução Normativa IN n. 28,
de 26 de julho de 2018, e inciso IV do art. 48 do Decreto Lei n. 986, de 21
de outubro de 1969<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=332&totalArquivos=400">Resolução-RE
nº 960, de 8 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: LIRIUS SUPLEMENTOS LTDA - CNPJ: 41971738000183
Produto - (Lote): SUPLEMENTO ALIMENTAR DE LUTEÍNA, ZEAXANTINA E VITAMINA D EM
CÁPSULAS, MARCA LIRIUS VISION (TODOS); Tipo de Produto: Alimento Expediente
nº: 0284223/24-8 Assunto: 70351 - Ações de Fiscalização em Vigilância
Sanitária Ações de fiscalização: Suspensão - Propaganda Motivação:
Considerando a realização de indicações terapêuticas, alegações funcionais e
de saúde não aprovadas e enganosas, em propagandas do Suplemento Alimentar de
luteína, zeaxantina e vitamina D em cápsulas, marca LIRIUS VISION/LIRIUS
SUPLEMENTOS, no site https://liriussuplementos.com.br, tais como nos exemplos
a seguir: "suporte à Saúde da Retina", "saúde da mácula,
preservando a função visual e prevenindo a degeneração macular relacionada à
idade", "melhora do Contraste e da Acuidade Visual, auxiliando na
clareza e nitidez da visão". Os sites e alegações mencionadas são meros
exemplos, logo, as medidas preventivas aqui dispostas se aplicam a todos
produtos similares e ambientes de divulgação sob responsabilidade das
empresas responsáveis. Foram infringidos os seguintes dispositivos legais:
Arts. 21 e 22, com base no 23 do Decreto Lei n. 986, de 21 de outubro de
1969; art. 16 e incisos I, II e IV do art. 17 da RDC n. 243, de 26 de julho
de 2018; art. 9 e Anexo V da Instrução Normativa - IN nº 28, de 26 de julho
de 2018; e art. 4 da Resolução RDC nº 727, de 1° de julho de 2022, tendo em
vista o inciso XXVI do art. 7º da Lei nº 9.782, de 26 de janeiro de 1999.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=89&totalArquivos=102">912</a><span class="MsoHyperlink">, </span><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=333&totalArquivos=400">951</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=333&totalArquivos=400">952</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=339&totalArquivos=400">957</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=87&totalArquivos=102">909</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=88&totalArquivos=102">910</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=89&totalArquivos=102">911</a><span class="MsoHyperlink">, </span><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=334&totalArquivos=400">953</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=335&totalArquivos=400">954</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=339&totalArquivos=400">955</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=339&totalArquivos=400">956</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">941</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">942</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">943</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">944</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=341&totalArquivos=400">945</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Distribuição e/ou Armazenagem.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=329&totalArquivos=400">893</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de Fabricação.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=329&totalArquivos=400">892</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=329&totalArquivos=400">894</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=330&totalArquivos=400">895</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=330&totalArquivos=400">903</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=331&totalArquivos=400">937</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=331&totalArquivos=400">938</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=331&totalArquivos=400">939</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=331&totalArquivos=400">940</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=331&totalArquivos=400">948</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=332&totalArquivos=400">958</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=333&totalArquivos=400">961</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Habilitação na Rede Brasileira de Laboratórios
Analíticos em Saúde (REBLAS).<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">957</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=340&totalArquivos=400">902</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Alimentos.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=280&totalArquivos=400">929</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Medicamentos e Produtos Biológicos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=281&totalArquivos=400">904</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=283&totalArquivos=400">905</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=283&totalArquivos=400">908</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=283&totalArquivos=400">923</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=284&totalArquivos=400">925</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 8;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Tecnologia de Produtos
para a Saúde.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=285&totalArquivos=400">913</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=288&totalArquivos=400">914</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=291&totalArquivos=400">915</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=292&totalArquivos=400">916</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=295&totalArquivos=400">917</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=326&totalArquivos=400">921</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 9;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência-Geral de Produtos Biológicos, Radiofármacos,
Sangue, Tecidos, Células, Órgãos e Produtos de Terapias Avançadas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=284&totalArquivos=400">924</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 10;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registro ou notificação de produtos para a saúde, cancelamento<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=297&totalArquivos=400">918</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=324&totalArquivos=400">919</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=325&totalArquivos=400">920</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="height: 29.25pt; mso-yfti-irow: 11;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 29.25pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registro sanitário de medicamentos, produtos biológicos e
insumos farmacêuticos, ou de apresentações, cancelamento<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 29.25pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=283&totalArquivos=400">906</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=283&totalArquivos=400">907</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 12;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Registros e petições <span style="color: black;">à Gerência Geral
de Produtos de Higiene, Perfumes, Cosméticos e Saneantes.</span><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=327&totalArquivos=400">926</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=327&totalArquivos=400">927</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=328&totalArquivos=400">928</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=328&totalArquivos=400">930</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=328&totalArquivos=400">931</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 13; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Resoluções, insubsistência.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=11/03/2024&jornal=515&pagina=326&totalArquivos=400">922</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" valign="top" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-26-2024-%20Nomear%20Defensoria%20dativa.pdf">Portaria
nº26/2024, de 07 de março de 2024</a></span></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" valign="top" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a nomeação da Defensoria
Dativa para Processos Ético-disciplinares do CRF/RS e dá outras providências</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-36374321461819464922024-03-08T10:32:00.000-03:002024-03-08T10:32:06.074-03:00CLIPPING CRF/RS 08/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/crf-rs-participa-de-seminario-sobre-saude-da-mulher-na-cosmam-da-camara-de-vereadores-de-poa">CRF/RS
participa de seminário sobre saúde da mulher na Cosmam da Câmara de
Vereadores de POA</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/07/03/2024/saude-investe-mais-de-r-200-milhoes-em-pesquisas-com-terapia-inovadora-para-tratamento-do-cancer">Saúde
investe mais de R$ 200 milhões em pesquisas com terapia inovadora para
tratamento do câncer</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/07/03/2024/camara-lanca-nova-versao-de-livro-sobre-a-vida-da-farmaceutica-maria-da-penha">Câmara
lança nova versão de livro sobre a vida da farmacêutica Maria da Penha</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/07/03/2024/mec-mantem-suspensao-do-credenciamento-de-cursos-ead-em-farmacia">MEC
mantém suspensão do credenciamento de cursos EAD em Farmácia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/governo-do-estado-antecipa-repasse-de-recursos-contra-a-dengue-a-municipios-gauchos">Governo
do Estado antecipa repasse de recursos contra a dengue a municípios gaúchos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-atualiza-requisitos-de-seguranca-e-desempenho-para-dispositivos-medicos">Anvisa
atualiza requisitos de segurança e desempenho para dispositivos médicos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-aprova-primeiro-produto-de-terapia-genica-para-tratamento-de-hemofilia-a-no-brasil">Anvisa
aprova primeiro produto de terapia gênica para tratamento de hemofilia A no
Brasil</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=66&totalArquivos=102">Portaria
GM/MS nº 3.128, de 19 de fevereiro de 2024(*)</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Portaria de Consolidação GM/MS nº 2, de 28 de setembro
de 2017, para instituir a Câmara Técnica Assessora em Atenção Cardiovascular
- CTA em Atenção Cardiovascular, no âmbito do Ministério da Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=67&totalArquivos=102">Portaria
GM/MS nº 3.231, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Portaria GM/MS nº 233, de 9 de março de 2023.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=68&totalArquivos=102">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">GM/MS</span> nº 3.283, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre as regras para as transferências do Fundo Nacional
de Saúde aos fundos de saúde dos Estados, Distrito Federal e Municípios,
relativas a emendas parlamentares que destinarem recursos ao Sistema Único de
Saúde (SUS), em 2024.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=73&totalArquivos=102">Portaria
SECTICS/MS nº 3, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar, no âmbito do Sistema
Único de Saúde - SUS, os testes moleculares para detecção de HPV oncogênico,
por técnica de amplificação de ácido nucléico baseada em PCR, com genotipagem
parcial ou estendida, validados analítica e clinicamente segundo critérios
internacionais para o rastreamento do câncer de colo de útero em população de
risco padrão e conforme as Diretrizes do Ministério da Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=73&totalArquivos=102">Resolução
Normativa ANS nº 600, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução Normativa - RN nº 465, de 24 de fevereiro de
2021, que dispõe sobre o Rol de Procedimentos e Eventos em Saúde no âmbito da
Saúde Suplementar, para regulamentar a cobertura obrigatória do procedimento
Diálise peritoneal automática (DPA), para a terapia renal substitutiva, em
cumprimento ao disposto nos parágrafos 4º e 10, do art. 10, da Lei nº
9.656/1998.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=75&totalArquivos=102">Instrução
Normativa - IN n° 283, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Aprova a lista de Normas Técnicas para a certificação de
conformidade dos equipamentos sob regime de Vigilância Sanitária<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=77&totalArquivos=102">Instrução
Normativa - IN n° 284, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Instrução Normativa - IN nº 28, de 26 de julho de 2018,
que estabelece as listas de constituintes, de limites de uso, de alegações e
de rotulagem complementar dos suplementos alimentares<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 8;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=78&totalArquivos=102">Resolução
da Diretoria Colegiada - RDC nº 846, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre as condições e os procedimentos para o registro de
vacinas influenza prépandêmicas, atualização para uma cepa pandêmica e
autorização de uso, comercialização e monitoramento das vacinas pandêmicas
contra influenza<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 9;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=80&totalArquivos=102">Resolução
da Diretoria Colegiada - RDC nº 847, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre os requisitos técnicos para regularização de tintas
e vernizes de uso imobiliário com ação saneante.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 10; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=83&totalArquivos=102">Resolução
da Diretoria Colegiada - RDC nº 848, de 6 de março de 2024</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre os requisitos essenciais de segurança e desempenho
aplicáveis aos dispositivos médicos e dispositivos médicos para diagnóstico
in vitro (IVD).<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=87&totalArquivos=102">Resolução-RE
nº 900, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: M.W.A.COMERCIO DE PRODUTOS ALIMENTICIOS LTDA - CNPJ:
53512810000193 Produto - (Lote): CANELA EM PO MARCA KODILAR (386-26); Tipo de
Produto: Alimento Expediente nº: 0274886/24-0 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Recolhimento
Suspensão - Comercialização, Distribuição, Uso Motivação: Considerando o
resultado do laudo de análise definitivo nº 830.1P.0/2023, emitido pela
Fundação Ezequiel Dias, Laboratório Central de Minas Gerais; que apresenta resultados
insatisfatórios quanto ao ensaio de pesquisa de matérias estranhas
indicativas de risco à saúde humana (pelo de roedor) e de falhas das Boas
Práticas (fragmentos de insetos) no lote 386-26 do produto Canela em pó,
marca Kodilar, validade: 05/10/2024; fabricado pela empresa M.W.A. COMÉRCIO
DE PRODUTOS ALIMENTÍCIOS LTDA., CNPJ: 53.512.810/0001-93. Foram infringidos o
disposto no inciso III do art. 9º da Resolução - RDC nº 623 de 9 de março de
2022; item 9 da Portaria SVS/MS nº 326, de 30 de julho de 1997 e inciso IV do
art. 48 do Decreto-Lei 986/1969; tendo em vista o inciso XV, art. 7º da Lei
nº 9.782, de 26 de janeiro de 1999 e o art. 9º da Resolução da Diretoria
Colegiada-RDC nº 655, de 24 de março de 2022<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=89&totalArquivos=102">Consulta
Pública nº 1.240, de 7 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">º Fica estabelecido o prazo de 45 (quarenta e cinco) dias para
envio de comentários e sugestões ao texto a ser incorporado na Farmacopeia
Brasileira sobre Denominações Comuns Brasileiras, conforme Anexo<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=89&totalArquivos=102">912</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=87&totalArquivos=102">909</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=88&totalArquivos=102">910</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=08/03/2024&jornal=515&pagina=89&totalArquivos=102">911</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-08&pg=91">Resolução
nº 078/24 – CIB/RS</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Pactuar a atualização do Anexo I da
Resolução CIB nº 050/22 - CIB/RS</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-79041812098289213632024-03-07T09:58:00.001-03:002024-03-07T09:58:14.955-03:00CLIPPING CRF/RS 07/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/06/03/2024/camara-aprova-reconhecimento-a-empresa-que-contratar-mulheres-com-cancer-de-mama">Câmara
aprova reconhecimento a empresa que contratar mulheres com câncer de mama</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/secretaria-da-saude-reforca-o-foco-no-atendimento-a-pacientes-com-dengue">Secretaria
da Saúde reforça o foco no atendimento a pacientes com dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-aprova-registro-da-vacina-spikevax-monovalente">Anvisa
aprova registro da vacina Spikevax monovalente</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinar-apresenta-nova-norma-de-dispositivos-medicos-para-diagnostico-in-vitro">Webinar
apresenta nova norma de dispositivos médicos para diagnóstico in vitro</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/projeto-com-a-visa-no-peito-quer-fortalecer-inspecao-nos-servicos-de-mamografia">Projeto
"Com a Visa no Peito" quer fortalecer inspeção nos serviços de
mamografia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/aprovada-resolucao-sobre-registro-de-vacinas-pre-pandemicas-contra-influenza">Aprovada
resolução sobre registro de vacinas pré-pandêmicas contra influenza</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-prioriza-registro-de-dispositivos-para-diagnostico-da-dengue">Anvisa
prioriza registro de dispositivos para diagnóstico da dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/prazo-para-aderir-ao-programa-de-retomada-de-obras-no-rio-grande-do-sul-termina-em-15-de-marco">Prazo
para aderir ao programa de retomada de obras no Rio Grande do Sul termina em
15 de março</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=53&totalArquivos=81">Portaria
SECTICS/MS nº 2, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar, no âmbito do Sistema
Único de Saúde - SUS, a hidroxiureia para o tratamento de pacientes com
doença falciforme (SS, Sbeta0, Sbeta+ grave e SD Punjab), entre 9 e 24 meses
de idade, sem sintomas e complicações, conforme Protocolo Clínico do
Ministério da Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS </span>nº 4, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar a hidroxiureia 100 mg para
o tratamento de pacientes com doença falciforme com pelo menos 9 meses de
idade, conforme Protocolo Clínico do Ministério da Saúde, e de não incorporar
a hidroxiureia 1000 mg para o tratamento de pacientes com doença falciforme
com pelo menos 9 meses de idade, no âmbito do Sistema Único de Saúde - SUS.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 5, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de, no âmbito do Sistema Único de Saúde
- SUS, incorporar o acetato de lanreotida para o tratamento de pacientes com
sintomas associados a tumores endócrinos gastroenteropancreáticos funcionais
e de não incorporar o acetato de octreotida de liberação prolongada para o
tratamento de pacientes com sintomas associados a tumores endócrinos
gastroenteropancreáticos funcionais.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 6, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar, no âmbito do Sistema
Único de Saúde - SUS, a ablação térmica para o tratamento da metástase
hepática irressecável ou ressecável com alto risco cirúrgico do câncer de
cólon e reto.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 5;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 7, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de atualizar, no âmbito do Sistema Único
de Saúde - SUS, o Protocolo Clínico e Diretrizes Terapêuticas de Diabete
Melito Tipo 2.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 6;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 8, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar, no âmbito do Sistema
Único de Saúde - SUS, o RT-PCR para identificação de mutação do receptor do
fator de crescimento epidérmico (EGFR) em pacientes com câncer de pulmão de
células não pequenas.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 7;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 9, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de manter a incorporação, no âmbito do
Sistema Único de Saúde - SUS, de nirmatrelvir/ritonavir para o tratamento da
Covid-19 para pacientes com sintomas leves a moderados, que não requerem
oxigênio suplementar, independentemente do status vacinal e com idade ³ 65
anos ou imunocomprometidos com idade ³ 18 anos.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 8; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=54&totalArquivos=81">Portaria
<span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 10, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de incorporar, no âmbito do Sistema
Único de Saúde - SUS, o ravulizumabe para o tratamento da hemoglobinúria
paroxística noturna, conforme Protocolo Clínico do Ministério da Saúde.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=53&totalArquivos=81">Consulta
Pública <span style="mso-ascii-font-family: Calibri; mso-bidi-font-family: Calibri; mso-hansi-font-family: Calibri;">SECTICS/MS</span> nº 6, de 5 de março
de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">O SECRETÁRIO DE CIÊNCIA, TECNOLOGIA E INOVAÇÃO E DO COMPLEXO
ECONÔMICO-INDUSTRIAL DA SAÚDE DO MINISTÉRIO DA SAÚDE torna pública, nos
termos do inciso III do art. 19-R da Lei nº 8.080, de 19 de setembro de 1990,
e do caput do art. 19 do Decreto nº 7.646, de 21 de dezembro de 2011,
consulta para manifestação da sociedade civil a respeito da recomendação do
Comitê de Medicamentos da Comissão Nacional de Incorporação de Tecnologias no
Sistema Único de Saúde - Conitec relativa à proposta de incorporação de derisomaltose
férrica para o tratamento de pacientes adultos com anemia por deficiência de
ferro, independente da causa, após falha terapêutica, intolerância ou
contraindicação aos sais de ferro oral, apresentada pela Pfizer Brasil, nos
autos de NUP 25000.133203/2023-15<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">Resolução-RE
nº 881, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote):
POMADA CAPILAR MATTE BARBEARIA VARGAS(TODOS); Tipo de Produto: Cosmético
Expediente nº: 0266079/24-2 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a fabricação do produto sem registro infringindo o art 12 da Lei
6360, de 23 de setembro de 1976 que traz em sua rotulagem o CNPJ
43.299.998/0001-80, AFE 2.06.575-2, responsável técnica Larrany Souza
Cardoso, CRF 37246 e tendo em vista o previsto no art 6º e inciso I do art.
67 da Lei 6360, de 23 de setembro de 1976 e inciso XV do art. 7º da Lei 9782,
de 26 de janeiro de 1999<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">Resolução-RE
nº 882, de 5 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: COSMODERMA INDÚSTRIA E COMÉRCIO LTDA-ME - CNPJ:
09601610000115 Produto - (Lote):TODOS OS PRODUTOS COSMÉTICOS(TODOS); Tipo de
Produto: Cosmético Expediente nº: 0266289/24-2 Assunto: 70358 - Revogação de
Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização
revogadas: Suspensão - Fabricação Motivação: Considerando a conclusão
satisfatória, no relatório de inspeção realizada no período de 19 a
21/02/2024, Ficha de Procedimento nº 01.000084/24, revoga-se a Resolução RE
nº. 4.412, de 17 de novembro de 2023,publicada no D.O.U, de 20/11/2023, seção
1, pág. 143.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">Resolução-RE
nº 884, de 6 de março de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote):
ISO WHEY ULTRA (FALSIFICADO) (TODOS); Tipo de Produto: Alimento Expediente
nº: 0266391/24-1 Assunto: 70351 - Ações de Fiscalização em Vigilância
Sanitária Ações de fiscalização: Apreensão Proibição - Comercialização,
Distribuição, Fabricação, Importação, Propaganda, Uso Motivação: Considerando
o recebimento de denúncia de falsificação do produto ISO WHEY ULTRA, 909g,
marca UNIVERSAL. O produto falsificado apresenta códigos de barras: 039442016249
e 039442016246 e cor predominante da embalagem: amarelo e é fabricado por
empresa desconhecida, infringindo o art. 41 e os incisos I e II do art. 48 do
DecretoLei nº 986 de 21 de outubro de 1969; tendo em vista o inciso XV, art.
7º da Lei nº 9.782, de 26 de janeiro de 1999.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 5; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">Resolução-RE
nº 891, de 6 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. -
CNPJ: N/A Produto - Apresentação (Lote): SUYA-IV (LOTE: 202207031B); Tipo de
Produto: Medicamento Expediente nº: 0262173/24-8 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Suspensão -
Distribuição, Importação, Uso Motivação: Comprovação da distribuição do
produto biológico Suya-IV (Imunoglobulina Humana), Fabricante Sichuan Yuanda
Shuyang Pharmaceutical Co., Ltd., lote 202207031B, em desacordo com os requisitos
de qualidade desejáveis, em função da constatação de corpos estranhos dentro
do frasco, contrariando o disposto no art. 4º da RDC 658/2022. Esta medida
preventiva está fundamentada nos art. 7º da Lei 6.360/1976.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">885</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=62&totalArquivos=81">890</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=56&totalArquivos=81">886</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=59&totalArquivos=81">887</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=62&totalArquivos=81">888</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=62&totalArquivos=81">889</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=63&totalArquivos=81">896</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=63&totalArquivos=81">897</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=63&totalArquivos=81">898</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=63&totalArquivos=81">899</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Resoluções, insubsistência.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=07/03/2024&jornal=515&pagina=55&totalArquivos=81">883</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-07&pg=95">Protocolo:
2024000969062</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de substâncias RETINÓICAS constantes da
relação C-2, Portaria SVS/MS 344/98 , o seguinte estabelecimento: Autorização
nº 356 Razão Social: Organizações Farmacêuticas Vieira e Guimarães LTDA Endereço
.: Av. Sete de Setembro, 2393, sala 02, bairro São Paulo Município : Tapejara
CEP: 99950-000 CNPJ : 52.815.846/0001-83 Processo/Proa : 24/2000-0030222-1</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-07&pg=95">Protocolo:
2024000969063</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) com cadastro aprovado para
comercializar medicamentos à base de substâncias RETINÓICAS constantes da
relação C-2, Portaria SVS/MS 344/98 , o seguinte estabelecimento: Autorização
nº 356 Razão Social: Organizações Farmacêuticas Vieira e Guimarães LTDA Endereço
.: Av. Sete de Setembro, 2393, sala 02, bairro São Paulo Município : Tapejara
CEP: 99950-000 CNPJ : 52.815.846/0001-83 Processo/Proa : 24/2000-0030222-1</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" valign="top" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-25-2024_Grupo-Apoio-Concurso-P%C3%BAblico%20-%20inclus%C3%A3o%20membro.pdf">Portaria
n.º 25/2024, de 06 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" valign="top" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Nomeia Comissão para realização de
Concurso Público do Conselho Regional de Farmácia do Estado do Rio Grande do
Sul e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-21544656181320987072024-03-06T08:57:00.004-03:002024-03-06T08:57:20.316-03:00CLIPPING CRF/RS 06/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/05/03/2024/pesquisa-mostra-que-diferenca-salarial-entre-mulheres-e-homens-caiu">Pesquisa
mostra que diferença salarial entre mulheres e homens caiu</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/05/03/2024/clonazepam-uso-abusivo-e-adiccao">Clonazepam:
uso abusivo e adicção</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/escola-de-saude-publica-recebe-ingressos-do-programa-de-residencia-integrada-em-saude">Escola
de Saúde Pública recebe ingressos do Programa de Residência Integrada em
Saúde</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/estado-destina-r-30-milhoes-para-reforma-e-ampliacao-de-unidades-basicas-de-saude">Estado
destina R$ 30 milhões para reforma e ampliação de Unidades Básicas de Saúde</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/dengue-nota-tecnica-orienta-sobre-triagem-para-doacao-de-sangue">Dengue:
nota técnica orienta sobre triagem para doação de sangue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/acompanhe-a-2a-reuniao-publica-de-2024-da-diretoria-colegiada">Acompanhe
a 2ª Reunião Pública de 2024 da Diretoria Colegiada</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/estrategia-em-acao-os-proximos-25-anos-comecam-aqui">Estratégia
em Ação: os próximos 25 anos começam aqui</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/marco/rio-grande-do-sul-ministerio-da-saude-atualiza-a-remuneracao-dos-agentes-de-saude">Rio
Grande do Sul: Ministério da Saúde atualiza a remuneração dos agentes de
saúde</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=124&totalArquivos=224">Portaria
GM/MS nº 3.154, de 9 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera o art. 4º e os Anexos VI, VII e VIII da Portaria GM/MS nº
674, de 6 de junho de 2023, que define e homologa os códigos referentes às
Identificações Nacionais de Equipe - INE das equipes da Atenção Primária à
Saúde - APS e ao Cadastro Nacional de Estabelecimentos de Saúde - CNES dos
serviços da Atenção Primária à Saúde - APS credenciados e cadastradas no
Sistema de Cadastro Nacional de Estabelecimentos de Saúde - SCNES, para fins
da transferência dos incentivos de custeio federal, acompanhamento, monitoramento
e avaliação.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=141&totalArquivos=224">Portaria
SAES/MS nº 1.187, de 27 de dezembro de 2023(*)</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Define o cadastramento dos Centros de Referência em Saúde do
Trabalhador no Cadastro Nacional de Estabelecimentos de Saúde (CNES), inclui
e altera procedimentos na Tabela de Procedimentos, Medicamentos, Órteses,
Próteses e Materiais Especiais do SUS<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=164&totalArquivos=224">Consulta
Pública nº 1.239, de 5 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 45 (quarenta e cinco) dias para
envio de comentários e sugestões ao texto da monografia beladona tintura
(folha), conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=164&totalArquivos=224">873</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=164&totalArquivos=224">874</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=158&totalArquivos=224">869</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=162&totalArquivos=224">870</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=163&totalArquivos=224">871</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=164&totalArquivos=224">872</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência-Geral de Produtos Biológicos, Radiofármacos,
Sangue, Tecidos, Células, Órgãos e Produtos de Terapias Avançadas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=158&totalArquivos=224">875</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=06/03/2024&jornal=515&pagina=158&totalArquivos=224">876</a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" valign="top" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-24-2024-Nomeacao-ASSECOM.pdf">Portaria
nº 24/2024, 05 de março de 2024</a></span></u><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" valign="top" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a nomeação e exoneração de
cargos em comissão e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/2_Portaria-11-2024_Grupo-Apoio-Concurso-P%C3%BAblico.pdf">Portaria
nº 11/2024, 06 de fevereiro de 2024 (Retificada)</a></span></span><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Nomeia Comissão para
realização de Concurso Público do Conselho Regional de Farmácia do Estado do
Rio Grande do Sul e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-64591952802333076632024-03-05T09:26:00.000-03:002024-03-05T09:26:23.749-03:00CLIPPING CRF/RS 05/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/estudo-da-fiocruz-revela-ineficacia-em-adultos-da-vacina-bcg-contra-tuberculose">Estudo
da Fiocruz revela ineficácia em adultos da vacina BCG contra tuberculose</a></span></u><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/estudo-indica-que-a-finasterida-pode-proteger-a-saude-do-coracao">Estudo
indica que a finasterida pode proteger a saúde do coração<span style="mso-fareast-language: EN-US;"><o:p></o:p></span></a></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/ufpe-se-estrutura-para-comecar-a-produzir-ifas-de-antineoplasicos">UFPE
se estrutura para começar a produzir IFAS de antineoplásicos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/automedicacao-sem-a-adequada-orientacao-pode-agravar-o-estado-de-saude-do-paciente">Automedicação
sem a adequada orientação pode agravar o estado de saúde do paciente</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/deputado-propoe-fornecimento-gratuito-de-caneta-de-adrenalina-autoinjetavel-pelo-sus">Deputado
propõe fornecimento gratuito de caneta de adrenalina autoinjetável pelo SUS</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/projeto-de-tratamento-da-menopausa-pelo-sus-avanca-no-senado">Projeto
de tratamento da menopausa pelo SUS avança no Senado</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/04/03/2024/presidente-da-cas-critica-sessao-contra-vacinacao-anticovid-em-criancas">Presidente
da CAS critica sessão contra vacinação anticovid em crianças</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/governo-do-estado-libera-ate-o-dia-15-recursos-para-o-combate-a-dengue-nos-municipios">Governo
do Estado libera até o dia 15 recursos para o combate à dengue nos municípios</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/artigo-faz-um-apanhado-das-licoes-aprendidas-durante-a-pandemia">Artigo
faz um apanhado das lições aprendidas durante a pandemia</a></span></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 11.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.2pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; font-size: 20.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=48&totalArquivos=76">Portaria
SAES/MS nº 1.509, de 28 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Revoga a Portaria SAES/MS nº 375, de 5 de agosto de 2022, que
atualiza, no Cadastro Nacional de Estabelecimentos de Saúde (CNES), o Serviço
Especializado de Atenção Psicossocial, incluindo o Tratamento em Regime de
Internação para Transtornos Mentais e Dependência Química<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.2pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; font-size: 20.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=49&totalArquivos=76">Resolução-RE
nº 868, de 4 de março de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: FLORA NATIVA DO BRASIL LTDA
(https://floranativadobrasil.com.br/) - CNPJ: 22455731000164 Produto -
(Lote): SUPLEMENTO ALIMENTAR DE LACTASE EM CÁPSULAS DA MARCA LACTINEA
(TODOS); Tipo de Produto: Alimento Expediente nº: 0260845/24-6 Assunto: 70351
- Ações de Fiscalização em Vigilância Sanitária Ações de fiscalização:
Proibição - Comercialização, Distribuição, Fabricação, Propaganda, Uso
Recolhimento Motivação: Considerando a fabricação, distribuição,
comercialização e propaganda do Suplemento Alimentar de lactase em cápsulas
sem o devido registro obrigatório, infringindo: item 5.2 da Resolução nº 23,
de 15 de março de 2000; anexo II da RDC nº 27, de 6 de agosto de 2010
(alterada pela RDC nº 240, de 26 de julho de 2018); art. 3 e incisos I e IV do
art. 48 do Decreto-Lei 986 de 21 de outubro de 1969, tendo em vista o inciso
XV, art. 7º da Lei nº 9.782, de 26 de janeiro de 1999 e o art. 9º da
Resolução da Diretoria Colegiada-RDC nº 655, de 24 de março de 2022.
......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: NORBERTO JUNIOR SUPLEMENTOS E COSMETICOS LTDA
(BIOVITAFEMME) - CNPJ: 48751258000156 Produto - (Lote): SUPLEMENTO ALIMENTAR
DE INOSITOL, VITAMINAS E MINERAIS EM CÁPSULAS DA MARCA SAISOP (TODOS); Tipo
de Produto: Alimento Expediente nº: 0253529/24-7 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Suspensão -
Propaganda Motivação: Considerando a realização de indicações terapêuticas,
alegações funcionais e de saúde não aprovadas e enganosas, em propagandas do
Suplemento Alimentar de Inositol, Vitaminas e Minerais em cápsulas da marca
SAISOP, no site https://lojabiovittafemme.com.br/ e no Mercado Livre, tais
como nos exemplos a seguir "Diminui as chances de aborto e malformações
na gestação; desenvolvimento saudável do feto e diminuição do risco de
abortos; Previne a diabetes, Previne o câncer, Combate vírus como: herpes,
Gripe, HIV, Varíola, HPV, etc.". Os sites e alegações mencionadas são
meros exemplos, logo, as medidas preventivas aqui dispostas se aplicam a todos
produtos similares e ambientes de divulgação sob responsabilidade da empresa
NORBERTO JUNIOR SUPLEMENTOS E COSMETICOS LTDA - 48.751.258/0001-56. Foram
infringidos os seguintes dispositivos legais: Arts. 21 e 22, com base no 23
do Decreto Lei n. 986, de 21 de outubro de 1969; art. 16 e incisos I, II e IV
do art. 17 da RDC n. 243, de 26 de julho de 2018; art. 9 e Anexo V da
Instrução Normativa - IN nº 28, de 26 de julho de 2018; e art. 4 da Resolução
RDC nº 727, de 1° de julho de 2022, tendo em vista o inciso XXVI do art. 7º
da Lei nº 9.782, de 26 de janeiro de 1999<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: .1pt; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.2pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; font-size: 20.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=49&totalArquivos=76">862</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=54&totalArquivos=76">867</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=50&totalArquivos=76">863</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=50&totalArquivos=76">864</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=54&totalArquivos=76">865</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=54&totalArquivos=76">866</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de Medicamentos e Produtos Biológicos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=05/03/2024&jornal=515&pagina=49&totalArquivos=76">837</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-49922400302038393122024-03-04T16:01:00.003-03:002024-03-04T16:01:49.178-03:00CONCURSOS PARA FARMACÊUTICO<p> </p><google-sheets-html-origin><table border="1" cellpadding="0" cellspacing="0" data-sheets-root="1" dir="ltr" style="border-collapse: collapse; border: none; font-family: Arial; font-size: 10pt; table-layout: fixed; width: 0px;" xmlns="http://www.w3.org/1999/xhtml"><colgroup><col width="347"></col></colgroup><tbody><tr style="height: 21px;"><td data-sheets-value="{"1":2,"2":"CONCURSO"}" style="border: 1px solid rgb(0, 0, 0); color: red; font-family: Calibri; font-weight: bold; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-align: center; vertical-align: bottom;">CONCURSO</td></tr><tr style="height: 21px;"><td data-sheets-hyperlink="https://novaboavista.rs.gov.br/pt_BR/noticias/788/-processo-seletivo-simplificado-n%C2%B0-0022024" data-sheets-value="{"1":2,"2":"Nova Boa Vista"}" style="background-color: white; border-color: rgb(204, 204, 204) rgb(0, 0, 0) rgb(0, 0, 0); border-image: initial; border-style: solid; border-width: 1px; color: #1155cc; font-family: Calibri; overflow-wrap: break-word; overflow: hidden; padding: 2px 3px; text-decoration-line: underline; vertical-align: bottom;"><a class="in-cell-link" href="https://novaboavista.rs.gov.br/pt_BR/noticias/788/-processo-seletivo-simplificado-n%C2%B0-0022024" target="_blank">Nova Boa Vista</a></td></tr></tbody></table></google-sheets-html-origin>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-77712494964401661012024-03-04T11:10:00.004-03:002024-03-04T11:10:47.983-03:00CLIPPING CRF/RS 04/03/2024<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr>
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Notícias Anvisa, SES/RS, CRF/RS, CFF, MS</span></b><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/01/03/2024/orientacoes-sobre-o-uso-de-repelentes"><span style="color: #1155cc;">Orientações sobre o uso de repelentes</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/01/03/2024/tiktok-substitui-o-google-como-ferramenta-de-busca-sobre-doencas-e-medicamentos-entre-os-mais-jovens"><span style="color: #1155cc;">Tiktok substitui o Google como ferramenta de busca
sobre doenças e medicamentos entre os mais jovens</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://saude.rs.gov.br/abertas-as-inscricoes-para-o-concurso-artistico-da-campanha-farmacia-vai-a-escola"><span style="color: #1155cc;">Abertas as inscrições para o concurso artístico da
campanha Farmácia vai à Escola</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://saude.rs.gov.br/mais-dois-obitos-por-dengue-sao-confirmados-no-rs-em-2024"><span style="color: #1155cc;">Mais dois óbitos por dengue são confirmados no RS em
2024</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://saude.rs.gov.br/cosud-vai-usar-app-contra-a-dengue-e-define-compras-conjuntas-de-medicamento"><span style="color: #1155cc;">Cosud vai usar app contra a dengue e define compras
conjuntas de medicamento</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<div style="background: white; border-bottom: none windowtext 1.0pt; border: none; margin-left: -.1pt; margin-right: 0cm; mso-border-bottom-alt: none windowtext 0cm; mso-element: para-border-div; padding: 0cm 0cm 7.0pt 0cm;">
<p class="MsoNormal" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: none; line-height: normal; margin: 6pt 0cm 6pt 0.1pt; padding: 0cm; text-indent: -0.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/aberta-consulta-publica-para-revisao-e-inclusao-de-monografias-da-farmacopeia"><span style="color: #1155cc;">Aberta consulta pública para revisão e inclusão de
monografias da Farmacopeia</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<p class="MsoNormal" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: none; line-height: normal; margin: 6pt 0cm 6pt 0.1pt; padding: 0cm; text-indent: -0.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinarda-anvisa-aborda-consulta-publica-sobre-cosmetovigilancia"><span style="color: #1155cc;">Webinar da Anvisa aborda consulta pública sobre
cosmetovigilância</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
<h1 style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: none; line-height: normal; margin: 6pt 0cm 6pt 0.1pt; padding: 0cm; text-indent: -0.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/seguranca-da-informacao-esclarecimento-sobre-a-recomendacao-de-troca-de-senha"><span style="color: #1155cc; font-weight: normal; mso-bidi-font-weight: bold; mso-fareast-font-family: Calibri;">Segurança da informação: esclarecimento sobre a
recomendação de troca de senha</span></a></span><u><span style="color: blue; font-family: "Calibri",sans-serif; font-size: 12.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></h1>
</div>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"> </span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="height: 26.9pt; mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; height: 26.9pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU
- Presidência/Ministério da Saúde</span></b><b><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 55.35pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=5&totalArquivos=228"><span style="color: #1155cc;">Instrução Normativa SAD/MAPA nº 140, de 28 de fevereiro
de 2024</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 55.35pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Aprova a Consolidação das Normas de Bebidas, Fermentados
Acéticos, Vinhos e Derivados da Uva e do Vinho, nacionais e importados<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=52&totalArquivos=228"><span style="color: #1155cc;">Portaria GM/MS nº 3.232, de 1º de março de 2024</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Portaria de Consolidação GM/MS nº 5, de 28 de setembro
de 2017, para instituir o Programa SUS Digital.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 19.5pt; mso-yfti-irow: 3;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 19.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=53&totalArquivos=228"><span style="color: #1155cc;">Portaria GM/MS nº 3.233, de 1º de março de 2024</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 19.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Regulamenta a etapa 1: planejamento, referente ao Programa SUS
Digital, de que trata o Anexo CVIII à Portaria de Consolidação GM/MS nº 5, de
28 de setembro de 2017, para o ano de 2024<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 4;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=111&totalArquivos=228"><span style="color: #1155cc;">Resolução nº 720, de 13 de setembro de 2023</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre o fluxo dos processos de atos autorizativos de
cursos de graduação da área da saúde no âmbito do Conselho Nacional de Saúde,
entre outras disposições.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 5; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=115&totalArquivos=228"><span style="color: #1155cc;">Portaria SAES/MS nº 1.187, de 27 de dezembro de 2023(*)</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Define o cadastramento dos Centros de Referência em Saúde do
Trabalhador no Cadastro Nacional de Estabelecimentos de Saúde (CNES), inclui
e altera procedimentos na Tabela de Procedimentos, Medicamentos, Órteses,
Próteses e Materiais Especiais do SUS<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"> </span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr>
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Ato normativo DOU - Recolhimentos/suspensão de
produtos/Consultas Públicas</span></b><b><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=115&totalArquivos=228"><span style="color: #1155cc;">Consulta Pública nº 1.238, de 29 de fevereiro de 2024</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 45 (quarenta e cinco) dias para
envio de comentários e sugestões ao texto da proposta de Instrução Normativa
- IN que altera a Instrução Normativa - IN nº 161, de 1º de julho de 2022,
que estabelece os padrões microbiológicos dos alimentos, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 23.15pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 23.15pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">Resolução-RE nº 845, de 1° de março de 2024</span></a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 23.15pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: TATIANA BITTENCOURT VILLELA NEVES - CNPJ:
32350165000180 Produto - (Lote): MARCA COSMÉTICOS ORA PRO NÓBIS(TODOS); Tipo
de Produto: Cosmético Expediente nº: 0241242/24-0 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Apreensão
Proibição - Comercialização, Distribuição, Fabricação, Propaganda, Uso
Motivação: Considerando a comercialização, exposição à venda de produtos
cosméticos sem registro por empresa sem autorização de funcionamento para a
fabricação, infringindo os arts. 2º e 12 da Lei 6.360, de 23 de setembro de
1976 e tendo em vista o previsto nos arts 6º, 7º e inciso I do art. 67 da Lei
6.360, de 23 de setembro de 1976<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"> </span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 685px;">
<tbody><tr>
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 513.75pt;" width="685">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Ato normativo DOU - ANVISA – Decisões
administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=184&totalArquivos=228"><span style="color: #1155cc;">859</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=184&totalArquivos=228"><span style="color: #1155cc;">860</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=184&totalArquivos=228"><span style="color: #1155cc;">861</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">AFE de empresas.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=115&totalArquivos=228"><span style="color: #1155cc;">848</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=182&totalArquivos=228"><span style="color: #1155cc;">855, 856</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=184&totalArquivos=228"><span style="color: #1155cc;">857</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=184&totalArquivos=228"><span style="color: #1155cc;">858</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=185&totalArquivos=228"><span style="color: #1155cc;">846</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=185&totalArquivos=228"><span style="color: #1155cc;">847</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de
Distribuição e/ou Armazenagem.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=176&totalArquivos=228"><span style="color: #1155cc;">785</span></a><u><span style="color: blue;">, </span></u><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">842</span></a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Certificação de Boas Práticas de
Fabricação.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=176&totalArquivos=228"><span style="color: #1155cc;">784</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=177&totalArquivos=228"><span style="color: #1155cc;">786</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=177&totalArquivos=228"><span style="color: #1155cc;">787</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=177&totalArquivos=228"><span style="color: #1155cc;">788</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=177&totalArquivos=228"><span style="color: #1155cc;">789</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=178&totalArquivos=228"><span style="color: #1155cc;">790</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=178&totalArquivos=228"><span style="color: #1155cc;">839</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=178&totalArquivos=228"><span style="color: #1155cc;">840</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=179&totalArquivos=228"><span style="color: #1155cc;">841</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">844</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">849</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">850</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=180&totalArquivos=228"><span style="color: #1155cc;">851</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=181&totalArquivos=228"><span style="color: #1155cc;">852</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=181&totalArquivos=228"><span style="color: #1155cc;">853</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Petições à Gerência
Geral de Alimentos.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;">802</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;">804</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Petições à Gerência Geral de
Medicamentos e Produtos Biológicos.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;">833</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=131&totalArquivos=228"><span style="color: #1155cc;">834</span></a>,<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=131&totalArquivos=228"><span style="color: #1155cc;"> 836</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=133&totalArquivos=228"><span style="color: #1155cc;">801</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Petições à Gerência
Geral de Tecnologia de Produtos para a Saúde.</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=161&totalArquivos=228"><span style="color: #1155cc;">807</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=165&totalArquivos=228"><span style="color: #1155cc;">808</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=167&totalArquivos=228"><span style="color: #1155cc;">809</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=168&totalArquivos=228"><span style="color: #1155cc;">810</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=170&totalArquivos=228"><span style="color: #1155cc;">811</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Petições à Gerência-Geral de
Produtos Biológicos, Radiofármacos, Sangue, Tecidos, Células, Órgãos e
Produtos de Terapias Avançadas.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=132&totalArquivos=228"><span style="color: #1155cc;">798</span></a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Registro ou notificação de
produtos para a saúde, cancelamento</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=134&totalArquivos=228"><span style="color: #1155cc;">805</span></a><u><span style="color: blue;"><o:p></o:p></span></u></span></p>
</td>
</tr>
<tr style="height: 29.25pt; mso-yfti-irow: 10;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; height: 29.25pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Registro sanitário de
medicamentos, produtos biológicos e insumos farmacêuticos, ou de
apresentações, cancelamento</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 29.25pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;"> 831</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;">832</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=131&totalArquivos=228"><span style="color: #1155cc;">835</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=132&totalArquivos=228"><span style="color: #1155cc;">799</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=133&totalArquivos=228"><span style="color: #1155cc;">800</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=160&totalArquivos=228"><span style="color: #1155cc;">806</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Registros e petições à Gerência Geral de Produtos de Higiene, Perfumes,
Cosméticos e Saneantes.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=128&totalArquivos=228"><span style="color: #1155cc;">803</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=173&totalArquivos=228"><span style="color: #1155cc;">812</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=173&totalArquivos=228"><span style="color: #1155cc;">813</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=174&totalArquivos=228"><span style="color: #1155cc;">814</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=175&totalArquivos=228"><span style="color: #1155cc;">815</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=175&totalArquivos=228"><span style="color: #1155cc;">816</span></a>, <a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=176&totalArquivos=228"><span style="color: #1155cc;">817</span></a><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.0pt;" width="504">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Resoluções,
insubsistência.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 135.75pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=04/03/2024&jornal=515&pagina=178&totalArquivos=228"><span style="color: #1155cc;">838</span></a></span><u><span style="color: blue; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"> </span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr>
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Ato normativo -
DOE/RS</span></b><b><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" valign="top" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-04&pg=120"><span style="color: #1155cc;">Protocolo: 202400096746</span></a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">(...) com cadastro aprovado para
comercializar medicamentos à base de SUBSTÂNCIAS RETINOICAS, constantes da
relação C-2, Portaria SV S/MS 344/98, o seguinte estabelecimento: Razão
Social: Comércio de Medicamentos Brair Ltda CNPJ: 88.212.113/1068-62 Endereço:
Rua Pernambuco, 904 CEP: 99.701-736 Município: Erechim/RS Processo Nº:
24/2000-0026773-6 Autorização Nº 02/ 2024 </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"> </span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr>
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="font-family: Calibri, sans-serif;"><a href="https://www.crfrs.org.br/transparencia"><b><span style="color: white; mso-fareast-font-family: Calibri;">Portal Transparência CRF/RS</span></b></a></span><b><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr>
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" valign="top" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://media.crfrs.org.br/transparencia/Portaria%2019-2024%20Nomea%C3%A7%C3%A3o%20e%20Exonera%C3%A7%C3%A3o%20Coord%20Fiscaliza%C3%A7%C3%A3o%20OT%20e%20Registros.pdf"><span style="color: #1155cc;">Portaria nº19/2024, de 29 de fevereiro de 2024</span></a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" valign="top" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Dispõe sobre a substituição da função
gratificada de coordenador do setor de fiscalização e orientação técnica e do
setor de registros do CRF/RS</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://media.crfrs.org.br/transparencia/Portaria-20-2024-Exonera%C3%A7%C3%A3o-Nomea%C3%A7%C3%A3o-TI.pdf"><span style="color: #1155cc;">Portaria nº20/2024, de 01 de março de 2024</span></a></span><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Dispõe sobre a substituição
no cargo de coordenador de Tecnologia da Informação e exoneração do cargo de
Líder Técnico do CRF/RS.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://media.crfrs.org.br/transparencia/1_Portaria-21-2024-Pregoeiro-Equipe-Apoio-Planejamento.pdf"><span style="color: #1155cc;">Portaria nº21/2024, de 29 de fevereiro de 2024</span></a></span><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Dispõe sobre a nomeação do
Pregoeiro e da Equipe de Apoio/Planejamento do CRF/RS, e dá outras
providências</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://media.crfrs.org.br/transparencia/Portaria-22-2024-Alteracao-Comissao-Permanente-Licitacao.pdf"><span style="color: #1155cc;">Portaria nº22/2024</span></a></span><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Dispõe sobre alteração da
Portaria nº 22/2023, referente à composição da Comissão Permanente de
Licitação (CPL) do CRF/RS e dá outras providências</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif; font-size: 10pt;"><a href="https://media.crfrs.org.br/transparencia/Portaria-23-2024-Comiss%C3%A3o%20executiva%20da%20nova%20sede.pdf"><span style="color: #1155cc;">Portaria nº23/2024, de 29 de fevereiro de 2024</span></a></span><u><span style="color: #1155cc; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></u></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: Calibri, sans-serif;">Nomeia Comissão para
realização de providências e demandas da nova sede do Conselho Regional de
Farmácia do Estado do Rio Grande do Sul e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table><p> </p>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-87795618222774079032024-03-01T11:03:00.002-03:002024-03-01T11:03:21.137-03:00CLIPPING CRF/RS 01/03/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/noticias/encontro-para-aprimora-estrategias-contra-a-dengue">Encontro
aprimora as estratégias contra a dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/noticias-do-cff/29/02/2024/justica-nega-liminar-a-sbd-e-mantem-a-resolucao-do-cff-sobre-tricologia">Justiça
nega liminar à SBD e mantém a Resolução do CFF sobre Tricologia</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/01/03/2024/opas-emite-alerta-epidemiologico-para-febre-oropouche-saiba-mais-sobre-a-doenca">OPAS
emite alerta epidemiológico para febre Oropouche. Saiba mais sobre a doença</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/governo-do-estado-gestores-e-entidades-acertam-reforco-nas-acoes-contra-a-dengue">Governo
do Estado, gestores e entidades acertam reforço nas ações contra a dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/confirmado-novo-obito-por-dengue-no-rs">Confirmado
novo óbito por dengue no RS</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://saude.rs.gov.br/distribuicao-gratuita-de-absorventes-pelo-sus-ja-esta-em-vigor-no-rio-grande-do-sul">Distribuição
gratuita de absorventes pelo SUS já está em vigor no Rio Grande do Sul</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-prioriza-analise-de-pedidos-de-registro-de-repelentes-de-insetos">Anvisa
prioriza análise de pedidos de registro de repelentes de insetos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-contribui-com-a-sustentabilidade-em-atualizacao-sobre-embalagens-de-alimentos">Anvisa
contribui com a sustentabilidade em atualização sobre embalagens de alimentos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=84&totalArquivos=149">Portaria
GM/MS nº 3.230, de 29 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Autoriza o repasse referente ao incremento financeiro
emergencial de custeio de resposta a emergências em saúde pública no âmbito
da Vigilância em Saúde do Sistema Único de Saúde.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="file:///C:/Users/marcia/Downloads/Clipping/Torna%20p%C3%BAblica%20a%20decis%C3%A3o%20de%20atualizar,%20no%20%C3%A2mbito%20do">Portaria
SECTICS/MS nº 7, de 28 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Torna pública a decisão de atualizar, no âmbito do Sistema Único
de Saúde - SUS, o Protocolo Clínico e Diretrizes Terapêuticas de Diabete
Melito Tipo 2<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=90&totalArquivos=149">Resolução-RE
nº 791, de 28 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: POWER SUPLEMENTOS LTDA (TOTAL SUPLEMENTOS) - CNPJ:
05914408000273 Produto - (Lote): SUPLEMENTO ALIMENTAR EM CÁPSULAS DA MARCA
INTIMATE PERFORMANCE (FALSIFICADO)(TODOS); Tipo de Produto: Alimento
Expediente nº: 0236469/24-7 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a denúncia de falsificação do Suplemento Alimentar INTIMATE
PERFORMANCE comercializado nas plataformas eletrônicas de venda
https://www.mercadolivre.com.br e https://www.shoptime.com.br, que consta com
a informação na rotulagem "Distribuído por Power Suplementos Ltda - CNPJ
05.914.408/0002-73", empresa BAIXADA na Receita Federal do Brasil. A
empresa fabricante do produto original, F.a.e Suplementos Nutricionais LTDA -
13.540.494/0003-00, não reconhece tal produção. Foram infringidos os
dispositivos legais: arts. 10, 21, 41, 45, 46 e 48 do Decreto-Lei nº 986, de
21 de outubro de 1969; art. 6, incisos IX e X do art. 7 e art. 29 da
Resolução da Diretoria Colegiada - RDC nº 727, de 1° de julho de 2022, tendo
em vista o inciso XV, art. 7º da Lei nº 9.782, de 26 de janeiro de 1999.
.........................................<o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><span style="mso-spacerun: yes;"> </span>2. Empresa: Templo
Espiritual Maria Santissima - CNPJ: 05543923000103 Produto - (Lote):
SUPLEMENTO MINERAL CUPRUM COLOIDAL (LÍQUIDO)(TODOS);SUPLEMENTO MINERAL
ARGENTUM COLOIDAL (LÍQUIDO)(TODOS);SUPLEMENTO MINERAL ZINCO COLOIDAL
(LÍQUIDO)(TODOS); Tipo de Produto: Alimento Expediente nº: 0236369/24-1
Assunto: 70351 - Ações de Fiscalização em Vigilância Sanitária Ações de
fiscalização: Apreensão Proibição - Comercialização, Distribuição,
Fabricação, Propaganda, Uso Motivação: Considerando a comercialização de
Suplementos Alimentares de origem desconhecida, no site
https://temsonline.com.br, além da realização de indicações terapêuticas,
alegações funcionais e de saúde não aprovadas em propagandas de alimentoss,
tais como "Previne a diabetes, Previne o câncer, Combate vírus como:
herpes, Gripe, HIV, Varíola, HPV". Foram infringidos os dispositivos
legais: arts. 10, 21, 23, 41, 45, 46 e 48 do Decreto-Lei nº 986, de 21 de
outubro de 1969; arts. 16 e 17 da Resolução da Diretoria Colegiada-RDC nº
243, de 26 de julho de 2018; Incisos I, II, VI, VII e VIII do Art. 4º, art.
6, incisos IX e X do art. 7 e art. 29 da Resolução da Diretoria Colegiada -
RDC nº 727, de 1° de julho de 2022, tendo em vista o inciso XV, art. 7º da
Lei nº 9.782, de 26 de janeiro de 1999. .........................................
<o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">3. Empresa: DESCONHECIDA - CNPJ: DESCONHECIDO Produto - (Lote):
NEW GLICO EM CÁPSULAS E NEW GLICO EM GOTAS(TODOS); Tipo de Produto: Alimento
Expediente nº: 0228625/24-4 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a comercialização na internet do suplemento alimentar, marca NEW
GLICO em cápsulas e NEW GLICO em gotas, de origem desconhecida, constituintes
não conhecidos e a realização de propaganda irregular na internet contendo
alegações terapêuticas e de saúde, para tratamento de doenças e problemas de
saúde relacionados à produção de insulina e ao controle aos níveis de glicose
no sangue, controle do Diabetes, prevenção do Alzheimer, prevenção do
infarto, redução do colesterol etc; além da afirmação inverídica que o
produto teria sido aprovado pela Anvisa. Infringindo: art. 21, c/c art. 23, e
inciso II do art. 48 do Decreto-Lei 986, de 1969; art. 2º do Decreto 7.962,
de 2013; inciso I, II, VI, VII e VIII do art. 4º da RDC nº 727, de 2022;
inciso I do art. 17 da RDC nº 243, de 2018 e Instrução Normativa nº 28, de
2018, tendo em vista o inciso XV, art. 7º da Lei nº 9.782, de 26 de janeiro
de 1999<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=93&totalArquivos=149">Consulta
Pública nº 1.237, de 27 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 60 (sessenta) dias para envio de
comentários e sugestões ao texto da monografia IODETO DE SÓDIO (123 I)
SOLUÇÃO ORAL, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=90&totalArquivos=149">792</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=92&totalArquivos=149">797</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=90&totalArquivos=149">793</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=91&totalArquivos=149">794</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=92&totalArquivos=149">795</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=01/03/2024&jornal=515&pagina=92&totalArquivos=149">796</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-03-01&pg=81">Protocolo:
2024000966874</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">(...) cadastro aprovado para comercializar
medicamentos à base de SUBSTÂNCIAS RETINOICAS, constantes da relação C-2,
Portaria SV S/MS 344/98, o seguinte estabelecimento: Razão Social: Comércio
de Medicamentos Brair Ltda CNPJ: 88.212.113/1068-62 Endereço: Rua Pernambuco,
904 CEP: 99.701-736 Município: Erechim/RS Processo Nº: 24/2000-0026773-6
Porto Alegre, Sexta-feira, 1 de Março de 2024 Diário Oficial Nº 41 81
Autorização Nº 02/ 2024</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/1_Portaria-16-2024-Substituicao-Ferias_Secretaria_Plenarias.pdf">Portaria
nº16/2024, de 28 de fevereiro de 2024</a><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a substituição da função Gratificada
de Responsabilidade por Secretarias de Plenárias do CRF/RS por motivo de
férias e dá outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/1_Portaria-%2017-2024%20Nomea%C3%A7%C3%A3o%20de%20Cargos%20em%20Comiss%C3%B5es%2026.02.2024.pdf">Portaria
nº17/2024, de 26 de fevereiro de 2024</a><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a nomeação de cargos em comissão e dá
outras providências.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria%2018-2024%20Nomea%C3%A7%C3%A3o%20e%20Exonera%C3%A7%C3%A3o%20Coord%20SSP%202024%20JOE%20e%20SHAIANE.pdf">Portaria
nº18/2024, de 26 de fevereiro de 2024</a><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Dispõe sobre a exoneração da função gratificada de
assessor de assuntos estratégicos e substituição no cargo de coordenador do
setor de serviços e patrimônios do CRF/RS</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-68070648240281059552024-02-29T09:20:00.000-03:002024-02-29T09:20:08.270-03:00CLIPPING CRF/RS 29/02/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/28/02/2024/com-o-dobro-de-casos-de-dengue-em-relacao-a-2023-brasil-tera-dia-d-de-combate-a-doenca">Com
o dobro de casos de dengue em relação a 2023, Brasil terá Dia D de combate à
doença</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/28/02/2024/castanhal-pa-recebe-selo-bronze-rumo-a-eliminacao-da-transmissao-vertical-da-sifilis">Castanhal
(PA) recebe Selo Bronze rumo à eliminação da transmissão vertical da sífilis</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/28/02/2024/farmaceutica-no-parana-acumula-quase-200-testes-de-dengue-realizados">Farmacêutica
no Paraná acumula quase 200 testes de dengue realizados</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/webinarapresenta-temas-da-agenda-regulatoria-da-area-de-alimentos">Webinar apresenta
temas da Agenda Regulatória da área de Alimentos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/todos-juntos-para-combater-o-mosquito-aedes-aegypti">Todos
juntos para combater o mosquito Aedes aegypti!</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-adota-nova-abordagem-regulatoria-para-area-de-alimentos">Anvisa
adota nova abordagem regulatória para área de Alimentos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/saude/pt-br/assuntos/noticias-para-os-estados/rio-grande-do-sul/2024/fevereiro/ministerio-da-saude-convoca-o-rio-grande-do-sul-para-dia-d-contra-a-dengue">Ministério
da Saúde convoca o Rio Grande do Sul para Dia D contra a dengue</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=49&totalArquivos=87">Portaria
Conjunta SAES/SECTICS nº 3, de 23 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Inclui procedimento e altera atributos de procedimentos
pertencentes ao Componente Especializado da Assistência Farmacêutica na
Tabela de Procedimentos, Medicamentos, Órteses, Próteses e Materiais
Especiais do SUS.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=56&totalArquivos=87">Resolução-RE
nº 774, de 28 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: Não Identificada - CNPJ: Desconhecido Produto -
Apresentação (Lote): BLINCYTO (LOTE: 1147922A); Tipo de Produto: Medicamento
Expediente nº: 0229166/24-5 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Uso Motivação: Comunicado da empresa detentora
do registro do medicamento Amgen Biotecnologia do Brasil, inscrita sob CNPJ
18.774.815/0001-93 ,informando a identificação, no mercado, de unidades deste
lote com características divergentes das constantes no medicamento original,
a saber: identificação de unidades do lote 1147922A, validade 08 de 2026, em
embalagem no idioma inglês e turco (não é fabricada unidades em idioma turco
para fora da Turquia), número de série apresentado na embalagem secundária
não foi gerado pela Amgen, o adesivo de serialização não corresponde à arte
da Amgen, assim como a fonte do adesivo e da embalagem, se tratando,
portanto, de falsificação. Esta medida preventiva está fundamentada no artigo
6º da Lei 6.360/1976 e inciso XV do artigo 7º da Lei 9.782/1999.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=56&totalArquivos=87">Resolução-RE
nº 775, de 28 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: BRUNA LOUISE SANTOS ALVES - CNPJ: 12493622618
Produto - (Lote): MARCA SEVLA NATURAL(TODOS); Tipo de Produto: Cosmético
Expediente nº: 0229037/24-5 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a comercialização, exposição à venda de produtos cosméticos sem
registro por empresa sem autorização de funcionamento para a fabricação,
infringindo os arts. 2º e 12 da Lei 6.360, de 23 de setembro de 1976 e tendo
em vista o previsto nos arts 6º, 7º e inciso I do art. 67 da Lei 6.360, de 23
de setembro de 1976. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: MARIANA DIAS VENANCIO - CNPJ: 36976324000107 Produto
- (Lote): MARCA IRACEMA PRODUTOS NATURAIS(TODOS); Tipo de Produto: Cosmético
Expediente nº: 0228846/24-0 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Apreensão Proibição -
Comercialização, Distribuição, Fabricação, Propaganda, Uso Motivação:
Considerando a comercialização, exposição à venda de produtos cosméticos sem
registro por empresa sem autorização de funcionamento para a fabricação,
infringindo os arts. 2º e 12 da Lei 6.360, de 23 de setembro de 1976 e tendo
em vista o previsto nos arts 6º, 7º e inciso I do art. 67 da Lei 6.360, de 23
de setembro de 1976<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=56&totalArquivos=87">Resolução-RE
nº 776, de 28 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">1. Empresa: Não Identificada - CNPJ: Desconhecido Produto -
Apresentação (Lote): PRODUTOS DE CANNABIS (LOTES: TODOS); Tipo de Produto:
Medicamento Expediente nº: 0224690/24-2 Assunto: 70351 - Ações de
Fiscalização em Vigilância Sanitária Ações de fiscalização: Apreensão
Proibição - Comercialização, Distribuição, Fabricação, Propaganda Motivação:
Comprovação da propaganda e anúncio de venda e comercialização dos produtos
sem registro, notificação ou cadastro na Anvisa, fabricados por empresa
desconhecida, em desacordo com os artigos 2º, 12, 50 e 59 da Lei nº
6.360/1976. As ações de fiscalização determinadas se aplicam a todos os
produtos anunciados no site www.terapianaturalbrasil.com, bem como a
quaisquer pessoas físicas/jurídicas ou veículos de comunicação que
comercializem ou divulguem os produtos. Esta medida preventiva está
fundamentada no artigo 6º da Lei nº 6.360/1976 e inciso XV do artigo 7º da
Lei nº 9.782/1999. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">2. Empresa: HALEX ISTAR INDÚSTRIA FARMACÊUTICA SA - CNPJ:
01.571.702/0001-98 Produto - Apresentação (Lote): ÁGUA PARA INJEÇÃO - SOL INJ
CX 200 AMP PLAS TRANS X 10 ML (LOTE: 2090389); Tipo de Produto: Medicamento
Expediente nº: 0219613/24-1 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Recolhimento Suspensão -
Comercialização, Distribuição, Uso Motivação: Confirmação do desvio de
qualidade referente à presença de corpo estranho na água para injeção,
solução injetável, o que fere artigo 4º da RDC 658/2022. Esta medida
preventiva está fundamentada no artigo 6º da Lei nº 6.360/1976 e na RDC nº
625/2022. ......................................... <o:p></o:p></span></p>
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">3. Empresa: NANDIS - COMERCIO DE GASES ATMOSFERICOS LTDA - CNPJ:
01.959.495/0001-43 Produto - Apresentação (Lote): OXIGÊNIO MEDICINAL (LOTES:
TODOS); NITROGÊNIO MEDICINAL (LOTES: TODOS); Tipo de Produto: Medicamento
Expediente nº: 0203532/24-4 Assunto: 70351 - Ações de Fiscalização em
Vigilância Sanitária Ações de fiscalização: Recolhimento Suspensão -
Comercialização, Distribuição, Uso Motivação: Confirmação de desvio de
qualidade em Boas Práticas de Fabricação e Envase de Gases Medicinais,
conforme verificado em inspeção ocorrida nos dias 10 a 11 de outubro de 2023
e, 03 de janeiro de 2024, o que fere os requerimentos dados pela RDC 658/2022
e IN 129/2022/ANVISA. Esta medida preventiva está fundamentada no artigo 6º
da Lei nº 6.360/1976 e na RDC nº 625/2022.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=56&totalArquivos=87">778</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=62&totalArquivos=87">782</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=63&totalArquivos=87">783</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=56&totalArquivos=87">779</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=61&totalArquivos=87">780</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=62&totalArquivos=87">781</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=63&totalArquivos=87">769</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/02/2024&jornal=515&pagina=63&totalArquivos=87">770</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #E36C09 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #E36C09; border-left: solid #E36C09 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato normativo - DOE/RS</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #E36C09 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-02-29&pg=12">Resolução
nº 240, de 27 de fevereiro de 2024.</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Institui, nos termos do Decreto nº 55.717, de 12 de
janeiro de 2021, os modelos-padrão de editais de licitações, de compras
públicas em geral, de termos de contratos e de outros instrumentos
complementares, no âmbito da Administração Pública Estadual.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: solid #E36C09 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #E36C09 6.0pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 133.35pt;" width="178">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.diariooficial.rs.gov.br/diario?td=DOE&dt=2024-02-29&pg=317">Instrução
Normativa IPE Saúde nº 08, de 28 de fevereiro de 2024.</a></span><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border: none; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 381.05pt;" valign="top" width="508">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Altera a Instrução Normativa IPE Saúde nº 01, de 31
de janeiro de 2024, que regulamenta a categorização da rede de prestadores de
serviços hospitalares do Sistema IPE Saúde; a Instrução Normativa nº 02, de
31 de janeiro de 2024, que institui a tabela própria de diárias, taxas e
serviços do Sistema IPE Saúde; a Instrução Normativa IPE Saúde nº 03, de 31
de janeiro de 2024, que dispõe sobre a instituição da tabela e orientação
técnica de farmaconutrientes empregados nas internações e atendimentos no
Sistema IPE Saúde; a Instrução Normativa IPE Saúde nº 04, de 31 de janeiro de
2024, que institui a tabela própria de medicamentos do IPE Saúde e dispõe
sobre a precificação de medicamentos empregados nas internações e
atendimentos aos usuários do Sistema IPE Saúde; a Instrução Normativa IPE
Saúde nº 05, de 31 de janeiro de 2024, que Institui a Tabela Própria de
Materiais Indenizáveis empregados nos atendimentos Porto Alegre,
Quinta-feira, 29 de Fevereiro de 2024 Diário Oficial Nº 40 317 aos usuários
do Sistema IPE Saúde e; a Instrução Normativa IPE Saúde nº 06, de 31 de
janeiro de 2024, que dispõe sobre a política da lista de preços de mercado –
LPM/IPE SAÚDE do Sistema IPE Saúde.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/Portaria-15-2024-Substitui%C3%A7%C3%A3o-Financeiro.pdf">Portaria
nº 15/2024, de 23 de fevereiro de 2024</a><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre a substituição da função Gratificada de
Responsabilidade por Transações Financeiras do CRF/RS por motivo de férias e
dá outras providências.</span><o:p></o:p></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #31849B 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/DeliberacaoDePlenaria-1789.2024-CTC.pdf">Deliberação
1.789/2024</a><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Nomeia a Comissão de Tomada de Contas para o exercício 2024/2025</span><o:p></o:p></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0tag:blogger.com,1999:blog-778744668561352250.post-1324232964983603832024-02-28T08:41:00.002-03:002024-02-28T08:41:50.486-03:00CLIPPING CRF/RS 28/02/2024<p> </p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.0pt; mso-border-left-alt: solid #548DD4 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1536; width: 684px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td style="background: #548DD4; border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.25pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Notícias
Anvisa, SES/RS, CRF/RS, CFF, MS<o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #548DD4 6.0pt; border: none; padding: 5.0pt 5.0pt 5.0pt 5.0pt; width: 513.25pt;" valign="top" width="684">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/02/2024/acido-hialuronico-cuidados-ao-realizar-procedimentos-com-o-preenchedor-facial-e-corporal">Ácido
hialurônico: cuidados ao realizar procedimentos com o preenchedor facial e
corporal</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://site.cff.org.br/noticia/Noticias-gerais/27/02/2024/farmaceutica-lanca-plataforma-gratuita-de-bulas-e-lembretes-para-quem-faz-uso-de-medicamentos">Farmacêutica
lança plataforma gratuita de bulas e lembretes para quem faz uso de
medicamentos</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/seminario-sobre-dispositivos-medicos-discutiu-papel-da-anvisa-na-inovacao">Seminário
sobre dispositivos médicos discutiu papel da Anvisa na inovação</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-language: EN-US; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2024/anvisa-divulga-resultado-do-edital-de-selecao-de-dispositivos-medicos-inovadores-para-projeto-piloto">Anvisa
divulga resultado do edital de seleção de dispositivos médicos inovadores</a></span></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #00B050; border-left: solid #00B050 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos
Normativos DOU - CFF</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-left: solid #00B050 6.0pt; border: solid #BFBFBF 1.0pt; mso-border-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #00B050 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=172&totalArquivos=178">Resolução
CFF nº 762, de 22 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #BFBFBF 1.0pt; border-left: none; border-right: none; border-top: solid #BFBFBF 1.0pt; mso-border-bottom-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #BFBFBF .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" valign="top" width="529">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Estabelece programa de parcelamento das receitas dos artigos 26
e 27, da Lei Federal nº 3.820, de 11 de novembro de 1960, viabilizando a
recuperação judicial e extrajudicial das sociedades empresárias farmacêuticas
e pessoas físicas inscritas nos quadros dos Conselhos Regionais de Farmácia.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #76923C 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #76923C; border-left: solid #76923C 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: -4.15pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 45.0pt center 236.15pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Atos Normativos DOU - Presidência/Ministério da
Saúde</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 1;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #76923C 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=103&totalArquivos=178">Resolução
Normativa ANS nº 599, de 26 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Altera a Resolução Normativa - RN nº 465, de 24 de fevereiro de
2021, que dispõe sobre o Rol de Procedimentos e Eventos em Saúde no âmbito da
Saúde Suplementar, para regulamentar a cobertura obrigatória do medicamento
Beta-agalsidase, para o tratamento da doença de Fabry clássica em pacientes
com oito anos de idade ou mais, em cumprimento ao disposto nos parágrafos 4º
e 10, do art. 10, da Lei nº 9.656/1998.<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 2;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=106&totalArquivos=178">Instrução
Normativa - IN n° 281, de 22 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Estabelece a forma de regularização das diferentes categorias de
alimentos e embalagens, e a respectiva documentação que deve ser apresentada<o:p></o:p></span></p>
</td>
</tr>
<tr style="height: 25.5pt; mso-yfti-irow: 3; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #76923C 6.0pt; border-right: solid #BFBFBF 1.0pt; border-top: none; height: 25.5pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #76923C 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 123.25pt;" width="164">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=109&totalArquivos=178">Resolução
- RDC nº 843, de 22 de fevereiro de 2024</a><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; height: 25.5pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 391.15pt;" width="522">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Dispõe sobre a regularização de alimentos e embalagens sob
competência do Sistema Nacional de Vigilância Sanitária (SNVS) destinados à
oferta no território nacional.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #C0504D 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #C0504D; border-left: solid #C0504D 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" valign="top" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - Recolhimentos/suspensão de produtos/Consultas Públicas</span></b><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-left: solid #C0504D 6.0pt; border: solid #D9D9D9 1.0pt; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=104&totalArquivos=178">Consulta
Pública nº 1.235, de 26 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 60 (sessenta) dias para envio de
comentários e sugestões ao texto da proposta de Resolução da Diretoria
Colegiada que dispõe sobre os requisitos sanitários aplicáveis aos silicones
utilizados em materiais, embalagens, revestimentos e equipamentos destinados
a entrar em contato com alimentos, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #C0504D 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #C0504D 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 117.5pt;" width="157">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=104&totalArquivos=178">Consulta
Pública nº 1.236, de 26 de fevereiro de 2024</a></span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 14.0cm;" width="529">
<p class="MsoNormal" style="border: none; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-border-shadow: yes; mso-padding-alt: 31.0pt 31.0pt 31.0pt 31.0pt; mso-pagination: none; text-align: justify; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Fica estabelecido o prazo de 60 (sessenta) dias para envio de
comentários e sugestões ao texto da proposta de Instrução Normativa que
estabelece as listas de substâncias que podem ser utilizadas na elaboração de
silicones utilizados em materiais, embalagens, revestimentos e equipamentos
destinados a entrar em contato com alimentos, conforme Anexo.<o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-insideh: .5pt solid #D9D9D9; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #8064A2 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #8064A2; border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: none; border-top: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato
normativo DOU - ANVISA – Decisões administrativas </span></b><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AE de </span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Empresas de Medicamentos e de Insumos Farmacêuticos.<span style="color: black;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=112&totalArquivos=178">761</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=112&totalArquivos=178">762</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=112&totalArquivos=178">763</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=117&totalArquivos=178">768</a><o:p></o:p></span></p>
</td>
</tr>
<tr style="mso-yfti-irow: 2; mso-yfti-lastrow: yes;">
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: solid #8064A2 6.0pt; border-right: solid #D9D9D9 1.0pt; border-top: none; mso-border-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #8064A2 6.0pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 378.4pt;" width="505">
<p class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 1.7pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 127.6pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">AFE de empresas.<o:p></o:p></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border: none; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 136.0pt;" width="181">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 3.3pt; margin-top: 6.0pt; mso-pagination: none; tab-stops: 348.95pt; text-align: center; text-indent: -.1pt;"><span style="font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=112&totalArquivos=178">764</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=116&totalArquivos=178">765</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=116&totalArquivos=178">766</a>,
<a href="https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=28/02/2024&jornal=515&pagina=117&totalArquivos=178">767</a><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 2.0cm; margin-top: 6.0pt; mso-pagination: none; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><sub><span style="color: #26397f; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p> </o:p></span></sub></b></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; border: none; margin-left: -5.75pt; mso-border-insidev: .5pt solid #D9D9D9; mso-border-left-alt: solid #31849B 6.0pt; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-table-layout-alt: fixed; mso-yfti-tbllook: 1024; width: 686px;">
<tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;">
<td colspan="2" style="background: #31849B; border-left: solid #31849B 6.0pt; border: none; padding: 0cm 5.4pt 0cm 5.4pt; width: 514.4pt;" width="686">
<p align="center" class="MsoNormal" style="line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-pagination: none; tab-stops: 104.95pt; text-align: center; text-indent: -.1pt;"><b style="mso-bidi-font-weight: normal;"><span style="color: white; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;">Ato Normativo – </span></b><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://www.crfrs.org.br/transparencia"><b style="mso-bidi-font-weight: normal;"><span style="color: white;">Portal Transparência CRF/RS</span></b></a></span><b style="mso-bidi-font-weight: normal;"><span style="color: #44546a; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></b></p>
</td>
</tr>
<tr style="mso-yfti-irow: 1; mso-yfti-lastrow: yes;">
<td style="border-bottom: #D9D9D9 1.0pt; border-left: #31849B 6.0pt; border-right: #BFBFBF 1.0pt; border-style: solid; border-top: #D9D9D9 1.0pt; mso-border-bottom-alt: #D9D9D9 .5pt; mso-border-left-alt: #31849B 6.0pt; mso-border-right-alt: #BFBFBF .5pt; mso-border-style-alt: solid; mso-border-top-alt: #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 130.25pt;" width="174">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; text-indent: -.1pt;"><span style="color: black; font-family: "Calibri",sans-serif; font-size: 10.0pt; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;"><a href="https://media.crfrs.org.br/transparencia/DeliberacaoDePlenaria-1790.2024-PF.PJ.pdf">Deliberação
de Plenária 1.790/2023</a></span><span class="MsoHyperlink"><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></span></p>
</td>
<td style="border-bottom: solid #D9D9D9 1.0pt; border-left: none; border-right: none; border-top: solid #D9D9D9 1.0pt; mso-border-bottom-alt: solid #D9D9D9 .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-left-alt: solid #BFBFBF .5pt; mso-border-top-alt: solid #D9D9D9 .5pt; padding: 0cm 5.4pt 0cm 5.4pt; width: 384.15pt;" width="512">
<p class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 6.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 6.0pt; mso-char-indent-count: 0; mso-hyphenate: auto; mso-outline-level: body-text; mso-para-margin-bottom: 6.0pt; mso-para-margin-left: 0gd; mso-para-margin-right: 0cm; mso-para-margin-top: 6.0pt; mso-vertical-align-alt: auto; text-align: justify; text-indent: 0cm;"><span style="color: black; font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-color-alt: windowtext; mso-hansi-theme-font: minor-latin;">Concessão de inscrição e baixa de profissionais e
registro e baixa de estabelecimentos junto ao CRF/RS.</span><span style="font-family: "Calibri",sans-serif; mso-ascii-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></p>
</td>
</tr>
</tbody></table>Centro de Documentação e Informação - CRF/RShttp://www.blogger.com/profile/03630903525692289028noreply@blogger.com0